<full-text-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/article/dtd" xmlns:bk="http://www.elsevier.com/xml/bk/dtd" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S258900421930015X</prism:url><dc:identifier>doi:10.1016/j.isci.2019.01.015</dc:identifier><eid>1-s2.0-S258900421930015X</eid><prism:doi>10.1016/j.isci.2019.01.015</prism:doi><pii>S2589-0042(19)30015-X</pii><dc:title>Mathematical Modeling Highlights the Complex Role of AKT in TRAIL-Induced Apoptosis of Colorectal Carcinoma Cells </dc:title><prism:publicationName>iScience</prism:publicationName><prism:aggregationType>Journal</prism:aggregationType><pubType>
               Article
            </pubType><prism:issn>25890042</prism:issn><prism:volume>12</prism:volume><prism:startingPage>182</prism:startingPage><prism:endingPage>193</prism:endingPage><prism:pageRange>182-193</prism:pageRange><dc:format>text/xml</dc:format><prism:coverDate>2019-02-22</prism:coverDate><prism:coverDisplayDate>22 February 2019</prism:coverDisplayDate><prism:copyright>© 2019 The Author(s).</prism:copyright><prism:publisher>The Author(s).</prism:publisher><dc:creator>Anderson, Matthew W.</dc:creator><dc:creator>Moss, Joanna J.</dc:creator><dc:creator>Szalai, Robert</dc:creator><dc:creator>Lane, Jon D.</dc:creator><dc:description>
               Summary
               
                  Protein kinase B/AKT is a highly connected protein involved in a range of signaling pathways. Although it is known to regulate several proteins in the apoptotic pathway, its system-level effects remain poorly understood. We investigated the dynamic interactions between AKT and key apoptotic proteins and constructed a deterministic ordinary differential equation protein interaction model of extrinsic apoptosis. Incorporating AKT and its indirect inhibitor, phosphatase and tensin homolog (PTEN), this was used to generate predictions of system dynamics. Using eigen analysis, we identified AKT and cytochrome c as the protein species most sensitive to perturbations. Cell death assays in Type II HCT116 colorectal carcinoma cells revealed a tendency toward Type I cell death behavior in the XIAP
                     
                        −/−
                      background, with cells displaying accelerated TRAIL-induced apoptosis. Finally, AKT inhibition experiments implicated AKT and not PTEN in influencing apoptotic proteins during early phases of TRAIL-induced apoptosis.
               
            </dc:description><openaccess>1</openaccess><openaccessArticle>true</openaccessArticle><openaccessType>Full</openaccessType><openArchiveArticle>false</openArchiveArticle><openaccessSponsorName>Engineering and Physical Sciences Research Council</openaccessSponsorName><openaccessSponsorType>FundingBody</openaccessSponsorType><openaccessUserLicense>http://creativecommons.org/licenses/by/4.0/</openaccessUserLicense><dcterms:subject>Cancer</dcterms:subject><dcterms:subject>Cell Biology</dcterms:subject><dcterms:subject>
                     In Silico Biology</dcterms:subject><link href="https://api.elsevier.com/content/article/pii/S258900421930015X" rel="self"/><link href="https://www.sciencedirect.com/science/article/pii/S258900421930015X" rel="scidir"/></coredata><objects><object ref="fx1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="164" height="164" size="17642">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-fx1.sml?httpAccept=%2A%2F%2A</object><object ref="gr1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="214" height="164" size="23759">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr1.sml?httpAccept=%2A%2F%2A</object><object ref="gr2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="192" height="164" size="17398">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr2.sml?httpAccept=%2A%2F%2A</object><object ref="gr3" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="99" size="12337">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr3.sml?httpAccept=%2A%2F%2A</object><object ref="gr4" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="121" size="13725">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr4.sml?httpAccept=%2A%2F%2A</object><object ref="gr5" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="193" height="164" size="19929">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr5.sml?httpAccept=%2A%2F%2A</object><object ref="gr6" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="128" height="164" size="19132">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr6.sml?httpAccept=%2A%2F%2A</object><object ref="fx1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="375" height="375" size="59842">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-fx1.jpg?httpAccept=%2A%2F%2A</object><object ref="gr1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="750" height="574" size="140435">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="583" height="497" size="98832">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref="gr3" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="583" height="263" size="56181">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr3.jpg?httpAccept=%2A%2F%2A</object><object ref="gr4" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="583" height="321" size="59603">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr4.jpg?httpAccept=%2A%2F%2A</object><object ref="gr5" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="752" height="639" size="126410">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr5.jpg?httpAccept=%2A%2F%2A</object><object ref="gr6" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="581" height="744" size="141934">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr6.jpg?httpAccept=%2A%2F%2A</object><object ref="fx1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="996" height="996" size="168192">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-fx1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="3323" height="2543" size="874096">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2582" height="2201" size="560850">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr3" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2582" height="1164" size="289368">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr3_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr4" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2582" height="1421" size="311213">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr4_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr5" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="3329" height="2830" size="803488">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr5_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr6" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2574" height="3295" size="851295">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-gr6_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="mmc3" category="standard" type="APPLICATION" multimediatype="ZIP file" mimetype="application/zip" size="9297">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-mmc3.zip?httpAccept=%2A%2F%2A</object><object ref="mmc1" category="standard" type="APPLICATION" multimediatype="Acrobat PDF file" mimetype="application/pdf" size="682969">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-mmc1.pdf?httpAccept=%2A%2F%2A</object><object ref="mmc2" category="standard" type="APPLICATION" multimediatype="Microsoft Excel file" mimetype="application/excel" size="13780">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-mmc2.xlsx?httpAccept=%2A%2F%2A</object><object ref="am" category="standard" type="AAM-PDF" multimediatype="Acrobat PDF file" mimetype="application/pdf" size="5069727">https://api.elsevier.com/content/object/eid/1-s2.0-S258900421930015X-am.pdf?httpAccept=%2A%2F%2A</object></objects><scopus-id>85065772264</scopus-id><scopus-eid>2-s2.0-85065772264</scopus-eid><link href="https://api.elsevier.com/content/abstract/scopus_id/85065772264" rel="abstract"/><originalText><xocs:doc xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd" xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd">
   <xocs:meta>
      <xocs:content-family>serial</xocs:content-family>
      <xocs:content-type>JL</xocs:content-type>
      <xocs:cid>318494</xocs:cid>
      <xocs:ssids>
         <xocs:ssid type="alllist">291210</xocs:ssid>
         <xocs:ssid type="subj">291711</xocs:ssid>
         <xocs:ssid type="subj">291777</xocs:ssid>
         <xocs:ssid type="subj">291802</xocs:ssid>
         <xocs:ssid type="subj">291848</xocs:ssid>
         <xocs:ssid type="content">31</xocs:ssid>
         <xocs:ssid type="oa">90</xocs:ssid>
      </xocs:ssids>
      <xocs:srctitle>iScience</xocs:srctitle>
      <xocs:normalized-srctitle>ISCIENCE</xocs:normalized-srctitle>
      <xocs:orig-load-date yyyymmdd="20190114">2019-01-14</xocs:orig-load-date>
      <xocs:available-online-date yyyymmdd="20190114">2019-01-14</xocs:available-online-date>
      <xocs:vor-load-date yyyymmdd="20190126">2019-01-26</xocs:vor-load-date>
      <xocs:vor-available-online-date yyyymmdd="20190126">2019-01-26</xocs:vor-available-online-date>
      <xocs:ew-transaction-id>2019-02-19T20:42:49</xocs:ew-transaction-id>
      <xocs:eid>1-s2.0-S258900421930015X</xocs:eid>
      <xocs:pii-formatted>S2589-0042(19)30015-X</xocs:pii-formatted>
      <xocs:pii-unformatted>S258900421930015X</xocs:pii-unformatted>
      <xocs:doi>10.1016/j.isci.2019.01.015</xocs:doi>
      <xocs:item-stage>S300</xocs:item-stage>
      <xocs:item-version-number>S300.1</xocs:item-version-number>
      <xocs:item-weight>FULL-TEXT</xocs:item-weight>
      <xocs:hub-eid>1-s2.0-S2589004219X00024</xocs:hub-eid>
      <xocs:timestamp yyyymmdd="20190423">2019-04-23T15:26:27.281232Z</xocs:timestamp>
      <xocs:dco>0</xocs:dco>
      <xocs:tomb>0</xocs:tomb>
      <xocs:date-search-begin>20190222</xocs:date-search-begin>
      <xocs:year-nav>2019</xocs:year-nav>
      <xocs:indexeddate epoch="1547491668">2019-01-14T18:47:48.807721Z</xocs:indexeddate>
      <xocs:articleinfo>absattachment articleinfo articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright crossmark dateloaded dateloadedtxt datesearch datesort dateupdated dco docsubtype doctype doi eid ewtransactionid fundingbodyid hubeid indexeddate issn issnnorm itemstage itemtransactionid itemweight oauserlicense openaccess openarchive pg pgfirst pglast pii piinorm pubdatestart pubdatetxt pubyr sectiontitle sortorder sponsoredaccesstype srctitle srctitlenorm srctype ssids alllist content oa subj subheadings suppl tomb volfirst volissue volumelist webpdf webpdfpagecount yearnav figure e-component body acknowledge affil appendices articletitle auth authfirstini authfull authkeywords authlast footnotes grantnumber grantsponsor grantsponsorid highlightsabst misctext orcid primabst pubtype ref specialabst teaserabst</xocs:articleinfo>
      <xocs:issns>
         <xocs:issn-primary-formatted>2589-0042</xocs:issn-primary-formatted>
         <xocs:issn-primary-unformatted>25890042</xocs:issn-primary-unformatted>
      </xocs:issns>
      <xocs:sponsored-access-type>UNLIMITED</xocs:sponsored-access-type>
      <xocs:funding-body-id>EPSRCC</xocs:funding-body-id>
      <xocs:crossmark is-crossmark="1">true</xocs:crossmark>
      <xocs:vol-first>12</xocs:vol-first>
      <xocs:volume-list>
         <xocs:volume>12</xocs:volume>
      </xocs:volume-list>
      <xocs:suppl>C</xocs:suppl>
      <xocs:vol-iss-suppl-text>Volume 12</xocs:vol-iss-suppl-text>
      <xocs:sort-order>15</xocs:sort-order>
      <xocs:first-fp>182</xocs:first-fp>
      <xocs:last-lp>193</xocs:last-lp>
      <xocs:pages>
         <xocs:first-page>182</xocs:first-page>
         <xocs:last-page>193</xocs:last-page>
      </xocs:pages>
      <xocs:cover-date-orig>
         <xocs:start-date>20190222</xocs:start-date>
      </xocs:cover-date-orig>
      <xocs:cover-date-text>22 February 2019</xocs:cover-date-text>
      <xocs:cover-date-start>2019-02-22</xocs:cover-date-start>
      <xocs:cover-date-year>2019</xocs:cover-date-year>
      <xocs:hub-sec>
         <xocs:hub-sec-title>Articles</xocs:hub-sec-title>
      </xocs:hub-sec>
      <xocs:document-type>article</xocs:document-type>
      <xocs:document-subtype>fla</xocs:document-subtype>
      <xocs:copyright-line>© 2019 The Author(s).</xocs:copyright-line>
      <xocs:normalized-article-title>MATHEMATICALMODELINGHIGHLIGHTSCOMPLEXROLEAKTINTRAILINDUCEDAPOPTOSISCOLORECTALCARCINOMACELLS</xocs:normalized-article-title>
      <xocs:normalized-first-auth-surname>ANDERSON</xocs:normalized-first-auth-surname>
      <xocs:normalized-first-auth-initial>M</xocs:normalized-first-auth-initial>
      <xocs:item-toc>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-section-title>Results</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-section-title>The AKT Apoptosis Model Predicts Protein Dynamics in Different Genetic Backgrounds</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-section-title>Eigen Analysis Reveals Perturbation Sensitivity of AKT and Cytochrome <ce:italic>c</ce:italic>
               </xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-section-title>Cell Death Assays Validate AKTM Predictions</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-section-title>Absence of BAX Expression in <ce:italic>PTEN</ce:italic>
                  <ce:sup loc="post">
                     <ce:italic>−/−</ce:italic>
                  </ce:sup> HCT116 Cells</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-section-title>AKT Regulates Early TRAIL-Induced Apoptosis</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-section-title>Discussion</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-section-title>Limitations of the Study</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-section-title>Methods</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:acknowledgment">
            <xocs:item-toc-section-title>Acknowledgments</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:appendices">
            <xocs:item-toc-section-title>Data and Software Availibility</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:appendices">
            <xocs:item-toc-section-title>Supplemental Information</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:bibliography">
            <xocs:item-toc-section-title>References</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
      </xocs:item-toc>
      <xocs:references>
         <xocs:ref-info refid="sref2">
            <xocs:ref-normalized-surname>ALDRIDGE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>553</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref4">
            <xocs:ref-normalized-surname>BAEHRECKE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2005</xocs:ref-pub-year>
            <xocs:ref-first-fp>505</xocs:ref-first-fp>
            <xocs:ref-last-lp>510</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref5">
            <xocs:ref-normalized-surname>BARNHART</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2003</xocs:ref-pub-year>
            <xocs:ref-first-fp>185</xocs:ref-first-fp>
            <xocs:ref-last-lp>193</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>SEMINARSINIMMUNOLOGY</xocs:ref-normalized-srctitle>
            <xocs:ref-normalized-article-title>CD95TYPEITYPEIIMODEL</xocs:ref-normalized-article-title>
         </xocs:ref-info>
         <xocs:ref-info refid="sref6">
            <xocs:ref-normalized-surname>BENTELE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>839</xocs:ref-first-fp>
            <xocs:ref-last-lp>851</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref11">
            <xocs:ref-normalized-surname>CARDONE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1998</xocs:ref-pub-year>
            <xocs:ref-first-fp>1318</xocs:ref-first-fp>
            <xocs:ref-last-lp>1321</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref15">
            <xocs:ref-normalized-surname>CUMMINS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>3006</xocs:ref-first-fp>
            <xocs:ref-last-lp>3008</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref16">
            <xocs:ref-normalized-surname>DAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>5405</xocs:ref-first-fp>
            <xocs:ref-last-lp>5412</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref17">
            <xocs:ref-normalized-surname>DAVOUDI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>4353</xocs:ref-first-fp>
            <xocs:ref-last-lp>4358</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Z</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref18">
            <xocs:ref-normalized-surname>DELPESO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1997</xocs:ref-pub-year>
            <xocs:ref-first-fp>687</xocs:ref-first-fp>
            <xocs:ref-last-lp>689</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref19">
            <xocs:ref-normalized-surname>DEVERAUX</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1999</xocs:ref-pub-year>
            <xocs:ref-first-fp>239</xocs:ref-first-fp>
            <xocs:ref-last-lp>252</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Q</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref20">
            <xocs:ref-normalized-surname>DONG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>1477</xocs:ref-first-fp>
            <xocs:ref-last-lp>1486</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref24">
            <xocs:ref-normalized-surname>FULDA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2006</xocs:ref-pub-year>
            <xocs:ref-first-fp>4798</xocs:ref-first-fp>
            <xocs:ref-last-lp>4811</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref25">
            <xocs:ref-normalized-surname>GILLISSEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>e643</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref27">
            <xocs:ref-normalized-surname>HERASSANDOVAL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>2694</xocs:ref-first-fp>
            <xocs:ref-last-lp>2701</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref30">
            <xocs:ref-normalized-surname>HUANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>11843</xocs:ref-first-fp>
            <xocs:ref-last-lp>11851</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref31">
            <xocs:ref-normalized-surname>JEONG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>83</xocs:ref-first-fp>
            <xocs:ref-last-lp>92</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref33">
            <xocs:ref-normalized-surname>KORNFELD</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>111</xocs:ref-first-fp>
            <xocs:ref-last-lp>115</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref36">
            <xocs:ref-normalized-surname>LEE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>6906</xocs:ref-first-fp>
            <xocs:ref-last-lp>6914</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref37">
            <xocs:ref-normalized-surname>LI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1997</xocs:ref-pub-year>
            <xocs:ref-first-fp>1943</xocs:ref-first-fp>
            <xocs:ref-last-lp>1947</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref38">
            <xocs:ref-normalized-surname>LIU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>583</xocs:ref-first-fp>
            <xocs:ref-last-lp>596</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref40">
            <xocs:ref-normalized-surname>MYERS</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1997</xocs:ref-pub-year>
            <xocs:ref-first-fp>9052</xocs:ref-first-fp>
            <xocs:ref-last-lp>9057</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref41">
            <xocs:ref-normalized-surname>NAKATANI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>629</xocs:ref-first-fp>
            <xocs:ref-last-lp>638</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref42">
            <xocs:ref-normalized-surname>OZOREN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2002</xocs:ref-pub-year>
            <xocs:ref-first-fp>551</xocs:ref-first-fp>
            <xocs:ref-last-lp>557</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>N</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref46">
            <xocs:ref-normalized-surname>SCAFFIDI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1998</xocs:ref-pub-year>
            <xocs:ref-first-fp>1675</xocs:ref-first-fp>
            <xocs:ref-last-lp>1687</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref49">
            <xocs:ref-normalized-surname>SCOTT</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2005</xocs:ref-pub-year>
            <xocs:ref-first-fp>645</xocs:ref-first-fp>
            <xocs:ref-last-lp>655</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>F</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref52">
            <xocs:ref-normalized-surname>VANTHEMSCHE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>20462</xocs:ref-first-fp>
            <xocs:ref-last-lp>20466</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref53">
            <xocs:ref-normalized-surname>WANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>3177</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref54">
            <xocs:ref-normalized-surname>WANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>e13393</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>Q</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref55">
            <xocs:ref-normalized-surname>WANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>956</xocs:ref-first-fp>
            <xocs:ref-last-lp>959</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref57">
            <xocs:ref-normalized-surname>WU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>AMINOACIDSBIOCHEMISTRYNUTRITION</xocs:ref-normalized-srctitle>
         </xocs:ref-info>
         <xocs:ref-info refid="sref60">
            <xocs:ref-normalized-surname>ZHANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2000</xocs:ref-pub-year>
            <xocs:ref-first-fp>989</xocs:ref-first-fp>
            <xocs:ref-last-lp>992</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
      </xocs:references>
      <xocs:refkeys>
         <xocs:refkey3>ANDERSONX2019X182</xocs:refkey3>
         <xocs:refkey4lp>ANDERSONX2019X182X193</xocs:refkey4lp>
         <xocs:refkey4ai>ANDERSONX2019X182XM</xocs:refkey4ai>
         <xocs:refkey5>ANDERSONX2019X182X193XM</xocs:refkey5>
      </xocs:refkeys>
      <xocs:open-access>
         <xocs:oa-article-status is-open-access="1" is-open-archive="0">Full</xocs:oa-article-status>
         <xocs:oa-access-effective-date>2019-01-10T08:26:41Z</xocs:oa-access-effective-date>
         <xocs:oa-sponsor>
            <xocs:oa-sponsor-type>FundingBody</xocs:oa-sponsor-type>
            <xocs:oa-sponsor-name>Engineering and Physical Sciences Research Council</xocs:oa-sponsor-name>
         </xocs:oa-sponsor>
         <xocs:oa-user-license>http://creativecommons.org/licenses/by/4.0/</xocs:oa-user-license>
      </xocs:open-access>
      <xocs:open-research>
         <xocs:or-agreements>
            <xocs:or-agreement>
               <xocs:or-agreement-name>HEFCE</xocs:or-agreement-name>
            </xocs:or-agreement>
         </xocs:or-agreements>
      </xocs:open-research>
      <xocs:copyright-info>
         <xocs:cp-license-lines>
            <xocs:cp-license-line lang="en">This is an open access article under the CC BY license.</xocs:cp-license-line>
         </xocs:cp-license-lines>
         <xocs:cp-notices>
            <xocs:cp-notice lang="en">© 2019 The Author(s).</xocs:cp-notice>
         </xocs:cp-notices>
      </xocs:copyright-info>
      <xocs:attachment-metadata-doc>
         <xocs:attachment-set-type>item</xocs:attachment-set-type>
         <xocs:pii-formatted>S2589-0042(19)30015-X</xocs:pii-formatted>
         <xocs:pii-unformatted>S258900421930015X</xocs:pii-unformatted>
         <xocs:eid>1-s2.0-S258900421930015X</xocs:eid>
         <xocs:doi>10.1016/j.isci.2019.01.015</xocs:doi>
         <xocs:cid>318494</xocs:cid>
         <xocs:timestamp>2019-04-23T15:26:27.281232Z</xocs:timestamp>
         <xocs:cover-date-start>2019-02-22</xocs:cover-date-start>
         <xocs:sponsored-access-type>UNLIMITED</xocs:sponsored-access-type>
         <xocs:funding-body-id>EPSRCC</xocs:funding-body-id>
         <xocs:attachments>
            <xocs:web-pdf>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-main.pdf</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/MAIN/application/pdf/05d537f5a99c016bb6f67ca5dfb68de5/main.pdf</xocs:ucs-locator>
               <xocs:filename>main.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:pdf-optimized>true</xocs:pdf-optimized>
               <xocs:filesize>4172550</xocs:filesize>
               <xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose>
               <xocs:web-pdf-page-count>34</xocs:web-pdf-page-count>
               <xocs:web-pdf-images>
                  <xocs:web-pdf-image>
                     <xocs:attachment-eid>1-s2.0-S258900421930015X-main_1.png</xocs:attachment-eid>
                     <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/PREVIEW/image/png/471958285288fc9183a6b44ca0016653/main_1.png</xocs:ucs-locator>
                     <xocs:filename>main_1.png</xocs:filename>
                     <xocs:extension>png</xocs:extension>
                     <xocs:filesize>33901</xocs:filesize>
                     <xocs:pixel-height>849</xocs:pixel-height>
                     <xocs:pixel-width>656</xocs:pixel-width>
                     <xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type>
                     <xocs:pdf-page-num>1</xocs:pdf-page-num>
                  </xocs:web-pdf-image>
               </xocs:web-pdf-images>
            </xocs:web-pdf>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-fx1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/fx1/THUMBNAIL/image/gif/44596eb553019738a7dee641c9beb511/fx1.sml</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>17642</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>164</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr1/THUMBNAIL/image/gif/769922d551f559b40e56982edf4ba00a/gr1.sml</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>23759</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>214</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr2/THUMBNAIL/image/gif/ef49a8d97a27332edbfdc166a44383fa/gr2.sml</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>17398</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>192</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr3.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr3/THUMBNAIL/image/gif/b5afe1b7fbaf3968492ae6358ae13043/gr3.sml</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>12337</xocs:filesize>
               <xocs:pixel-height>99</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr4.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr4/THUMBNAIL/image/gif/c16978cdf730c76d2599e7f79b7a4295/gr4.sml</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>13725</xocs:filesize>
               <xocs:pixel-height>121</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr5.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr5/THUMBNAIL/image/gif/47a2ae07a5ee1966fa92c62c3fbdae6d/gr5.sml</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>19929</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>193</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr6.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr6/THUMBNAIL/image/gif/7b2cd00779b53b17365943a3a5aa76c5/gr6.sml</xocs:ucs-locator>
               <xocs:file-basename>gr6</xocs:file-basename>
               <xocs:filename>gr6.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>19132</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>128</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-fx1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/fx1/DOWNSAMPLED/image/jpeg/2335b07c0f170560bbd10bc7d6e7b1d9/fx1.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>59842</xocs:filesize>
               <xocs:pixel-height>375</xocs:pixel-height>
               <xocs:pixel-width>375</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr1/DOWNSAMPLED/image/jpeg/b0e40cdcf114e72fd182481e568752b8/gr1.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>140435</xocs:filesize>
               <xocs:pixel-height>574</xocs:pixel-height>
               <xocs:pixel-width>750</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr2/DOWNSAMPLED/image/jpeg/af9940f6b530b24ed97cde21ef57ab93/gr2.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>98832</xocs:filesize>
               <xocs:pixel-height>497</xocs:pixel-height>
               <xocs:pixel-width>583</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr3.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr3/DOWNSAMPLED/image/jpeg/86caefe99ff7730cf550909aa6376f19/gr3.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>56181</xocs:filesize>
               <xocs:pixel-height>263</xocs:pixel-height>
               <xocs:pixel-width>583</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr4.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr4/DOWNSAMPLED/image/jpeg/2009ec311e90235e1c47f795c90e74eb/gr4.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>59603</xocs:filesize>
               <xocs:pixel-height>321</xocs:pixel-height>
               <xocs:pixel-width>583</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr5.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr5/DOWNSAMPLED/image/jpeg/5c5459d3b81fd570ab223b1abcba9169/gr5.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>126410</xocs:filesize>
               <xocs:pixel-height>639</xocs:pixel-height>
               <xocs:pixel-width>752</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr6.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr6/DOWNSAMPLED/image/jpeg/d6949b050b9f8382bced1a0e3171b729/gr6.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr6</xocs:file-basename>
               <xocs:filename>gr6.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>141934</xocs:filesize>
               <xocs:pixel-height>744</xocs:pixel-height>
               <xocs:pixel-width>581</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-fx1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/fx1/HIGHRES/image/jpeg/3c5b7b9b6c41e1350075cfe26f05281c/fx1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>168192</xocs:filesize>
               <xocs:pixel-height>996</xocs:pixel-height>
               <xocs:pixel-width>996</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr1/HIGHRES/image/jpeg/aa27fdc28786996ea91d2248f412d6fa/gr1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>874096</xocs:filesize>
               <xocs:pixel-height>2543</xocs:pixel-height>
               <xocs:pixel-width>3323</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr2_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr2/HIGHRES/image/jpeg/67255d1f63bca8785b2d7729eeebd6ca/gr2_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>560850</xocs:filesize>
               <xocs:pixel-height>2201</xocs:pixel-height>
               <xocs:pixel-width>2582</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr3_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr3/HIGHRES/image/jpeg/c5ca0023f93777a02430b65bcbcb4d45/gr3_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>289368</xocs:filesize>
               <xocs:pixel-height>1164</xocs:pixel-height>
               <xocs:pixel-width>2582</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr4_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr4/HIGHRES/image/jpeg/181bee734a27b68e5035bf384bd1a24b/gr4_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>311213</xocs:filesize>
               <xocs:pixel-height>1421</xocs:pixel-height>
               <xocs:pixel-width>2582</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr5_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr5/HIGHRES/image/jpeg/54412497d5f9e65ba4afc010a15f7aac/gr5_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>803488</xocs:filesize>
               <xocs:pixel-height>2830</xocs:pixel-height>
               <xocs:pixel-width>3329</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-gr6_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/gr6/HIGHRES/image/jpeg/da52fa1dad9a2d7d3f72157a75d20a92/gr6_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr6</xocs:file-basename>
               <xocs:filename>gr6_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>851295</xocs:filesize>
               <xocs:pixel-height>3295</xocs:pixel-height>
               <xocs:pixel-width>2574</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-mmc3.zip</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/mmc3/MAIN/application/zip/dd1c7543dbf847cd3c24f01f31d16a68/mmc3.zip</xocs:ucs-locator>
               <xocs:file-basename>mmc3</xocs:file-basename>
               <xocs:filename>mmc3.zip</xocs:filename>
               <xocs:extension>zip</xocs:extension>
               <xocs:filesize>9297</xocs:filesize>
               <xocs:attachment-type>APPLICATION</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-mmc1.pdf</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/mmc1/MAIN/application/pdf/77aca1da81e957d750d2210c5763f20d/mmc1.pdf</xocs:ucs-locator>
               <xocs:file-basename>mmc1</xocs:file-basename>
               <xocs:filename>mmc1.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:pdf-optimized>false</xocs:pdf-optimized>
               <xocs:filesize>682969</xocs:filesize>
               <xocs:attachment-type>APPLICATION</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-mmc2.xlsx</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S258900421930015X/mmc2/MAIN/application/vnd.openxmlformats-officedocument.spreadsheetml.sheet/ac2c9e8315098641dc856f06218abf1c/mmc2.xlsx</xocs:ucs-locator>
               <xocs:file-basename>mmc2</xocs:file-basename>
               <xocs:filename>mmc2.xlsx</xocs:filename>
               <xocs:extension>xlsx</xocs:extension>
               <xocs:filesize>13780</xocs:filesize>
               <xocs:attachment-type>APPLICATION</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S258900421930015X-am.pdf</xocs:attachment-eid>
               <xocs:file-basename>am</xocs:file-basename>
               <xocs:filename>am.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:filesize>5069727</xocs:filesize>
               <xocs:attachment-type>AAM-PDF</xocs:attachment-type>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/egi:10W4L3GXM3H/MAIN/application/pdf/032c5651319073b29e229bb229257309/am.pdf</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/egi:10W4L3GXM3H/MAIN/application/pdf/032c5651319073b29e229bb229257309/am.pdf</xocs:ucs-locator>
            </xocs:attachment>
         </xocs:attachments>
      </xocs:attachment-metadata-doc>
   </xocs:meta>
   <xocs:serial-item>
      <article xmlns="http://www.elsevier.com/xml/ja/dtd" docsubtype="fla" version="5.5" xml:lang="en">
         <item-info>
            <jid>ISCI</jid>
            <aid>283</aid>
            <ce:pii>S2589-0042(19)30015-X</ce:pii>
            <ce:doi>10.1016/j.isci.2019.01.015</ce:doi>
            <ce:copyright type="other" year="2019">The Author(s)</ce:copyright>
         </item-info>
         <ce:floats>
            <ce:figure id="fig1">
               <ce:label>Figure 1</ce:label>
               <ce:caption id="cap0020">
                  <ce:simple-para id="fspara0010" view="all">The AKT Apoptosis Model Predicts Protein Dynamics in Different Genetic Backgrounds</ce:simple-para>
                  <ce:simple-para id="fspara0015" view="all">(A) Extrinsic apoptosis signaling pathway.</ce:simple-para>
                  <ce:simple-para id="fspara0020" view="all">(B) The AKT apoptosis model (AKTM). Protein species shown in green are those for which double knockout HCT116 cell lines are used in this study. TRAIL, TNF-related apoptosis-inducing ligand; C8, active caspase-8; BAX, Bcl-2-associated X protein; Bcl-2, B-cell lymphoma 2; SMAC, second mitochondria-derived activator of caspases; CytoC, cytochrome <ce:italic>c</ce:italic>; XIAP, X-linked inhibitor of apoptosis protein; AKT, protein kinase B; PTEN, phosphatase and tensin homolog; C3, active caspase-3.</ce:simple-para>
                  <ce:simple-para id="fspara0025" view="all">(C) Predicting the effects of BAX removal on the AKTM. Green lines signify a predicted increased response, and red lines signify a reduced response.</ce:simple-para>
                  <ce:simple-para id="fspara0030" view="all">(D) Predicted effects of XIAP removal on the AKTM.</ce:simple-para>
                  <ce:simple-para id="fspara0035" view="all">(E) Predicted effects of PTEN removal on the AKTM.</ce:simple-para>
                  <ce:simple-para id="fspara0040" view="all">(F) Predicted effects of AKT removal on the AKTM.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr1" xlink:type="simple" xlink:href="pii:S258900421930015X/gr1"/>
            </ce:figure>
            <ce:figure id="fig2">
               <ce:label>Figure 2</ce:label>
               <ce:caption id="cap0025">
                  <ce:simple-para id="fspara0045" view="all">AKTM Simulation Results</ce:simple-para>
                  <ce:simple-para id="fspara0050" view="all">(A–H and J–M) Simulated concentrations of the following protein species in the HCT116 wild-type, <ce:italic>BAX</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup>, <ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup>, <ce:italic>XIAP</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup>, and <ce:italic>AKT</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> cell lines for a 16-h period following exposure to TRAIL and cycloheximide: (A) TRAIL, (B) active caspase-8, (C) active caspase-3, (D) active BAX, (E) Bcl-2, (F) mitochondrial pore, (G) cytochrome <ce:italic>c</ce:italic>, (H) SMAC, (J) XIAP, (K) active AKT, (L) PTEN, and (M) cleaved PARP.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr2" xlink:type="simple" xlink:href="pii:S258900421930015X/gr2"/>
            </ce:figure>
            <ce:figure id="fig3">
               <ce:label>Figure 3</ce:label>
               <ce:caption id="cap0030">
                  <ce:simple-para id="fspara0055" view="all">Eigen Analysis Reveals Perturbation Sensitivity of AKT and Cytochrome <ce:italic>c</ce:italic>
                  </ce:simple-para>
                  <ce:simple-para id="fspara0060" view="all">(A–C) Eigen analysis of the three positive eigenvalues present in the wild-type system: (A) eigenvalue 1 (most positive), (B) eigenvalue 2, and (C) eigenvalue 3 (least positive).</ce:simple-para>
                  <ce:simple-para id="fspara0065" view="all">(D) The temporally variable protein species most responsible for eigenvalue 1 dynamics: (i) active AKT, (ii) PARP, (iii) cytosolic cytochrome <ce:italic>c</ce:italic>, and (iv) mitochondrial cytochrome <ce:italic>c</ce:italic>.</ce:simple-para>
                  <ce:simple-para id="fspara0070" view="all">(E) Eigenvalue 2 dynamics: (i) cleaved PARP, (ii) mitochondrial cytochrome <ce:italic>c</ce:italic>, and (iii) cytosolic cytochrome <ce:italic>c</ce:italic>.</ce:simple-para>
                  <ce:simple-para id="fspara0075" view="all">(F) Eigenvalue 3 dynamics: (i) cytosolic cytochrome <ce:italic>c</ce:italic>, (ii) cleaved PARP, and (iii) PARP.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr3" xlink:type="simple" xlink:href="pii:S258900421930015X/gr3"/>
            </ce:figure>
            <ce:figure id="fig4">
               <ce:label>Figure 4</ce:label>
               <ce:caption id="cap0035">
                  <ce:simple-para id="fspara0080" view="all">Cell Death Assays Validate AKTM Predictions</ce:simple-para>
                  <ce:simple-para id="fspara0085" view="all">(A) Percentage cell death in untreated (control) HCT116 cells.</ce:simple-para>
                  <ce:simple-para id="fspara0090" view="all">(B) Percentage cell death in HCT116 cells treated with 2.5 μg/mL cycloheximide.</ce:simple-para>
                  <ce:simple-para id="fspara0095" view="all">(C) Percentage cell death in HCT116 cells treated with 50 ng/mL TRAIL and 2.5 μg/mL cycloheximide.</ce:simple-para>
                  <ce:simple-para id="fspara0100" view="all">(D) Time to 50% cell death in HCT116 cells treated with 50 ng/mL TRAIL and 2.5 μg/mL cycloheximide. <ce:italic>BAX</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> cells reached 50% cell death significantly later than in wild-type (p &lt; 0.05), <ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> cells did not significantly differ from wild-type, and <ce:italic>XIAP</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> cells reached 50% cell death significantly earlier (p &lt; 0.01).</ce:simple-para>
                  <ce:simple-para id="fspara0110" view="all">Data in (A–D) represent means ± SD from three independent biological repeats. SDs are represented by shaded areas in (A–C) and by error bars in (D). * in (D) indicates a mean significantly different from that of the wild-type cell line with p ≤ 0.05 (Welch two-sample t test); ** signifies p ≤ 0.01. Detailed statistical results are displayed in <ce:cross-ref refid="mmc2" id="crosref0635">Table S5</ce:cross-ref>.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr4" xlink:type="simple" xlink:href="pii:S258900421930015X/gr4"/>
            </ce:figure>
            <ce:figure id="fig5">
               <ce:label>Figure 5</ce:label>
               <ce:caption id="cap0040">
                  <ce:simple-para id="fspara0115" view="all">Absence of BAX Expression in <ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> HCT116 Cells</ce:simple-para>
                  <ce:simple-para id="fspara0120" view="all">(A–G) (A) Immunoblotting via western blot of wild-type, <ce:italic>BAX</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup>, <ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup>, and <ce:italic>XIAP</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> HCT116 cell lines for the following proteins: AKT, p-AKT (Ser<ce:sup loc="post">473</ce:sup>), PTEN, XIAP, BAX, and α-tubulin as a loading control. Densitometry quantitation of (B) AKT, (C) p-AKT Ser<ce:sup loc="post">473</ce:sup>, (D) PTEN, (E) XIAP, (F) BAX, and (G) tubulin.</ce:simple-para>
                  <ce:simple-para id="fspara0125" view="all">(H) qRT-PCR of BAX mRNA levels in wild-type, <ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup>, and <ce:italic>BAX</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> cells.</ce:simple-para>
                  <ce:simple-para id="fspara0130" view="all">(J) Immunoblot of immunoprecipitated endogenous BAX and PTEN from wild-type HCT116 cells; FLAG antibody used as a negative control, and 5% of protein lysate used as control for protein expression.</ce:simple-para>
                  <ce:simple-para id="fspara0135" view="all">(K) siRNA-mediated silencing of PTEN in wild-type HCT116 cells.</ce:simple-para>
                  <ce:simple-para id="fspara0140" view="all">Data in (B–G) represent normalized means (relative to wild-type = 1) from three independent biological repeats ± SD. * indicates a mean significantly different from that of the wild-type cell line with p ≤ 0.05 (Welch two-sample t test); *** signifies p ≤ 0.001. Detailed statistical results are displayed in <ce:cross-ref refid="mmc2" id="crosref0640">Table S5</ce:cross-ref>.</ce:simple-para>
                  <ce:simple-para id="fspara0145" view="all">See also <ce:cross-ref refid="mmc1" id="crosref0645">Figure S1</ce:cross-ref>.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr5" xlink:type="simple" xlink:href="pii:S258900421930015X/gr5"/>
            </ce:figure>
            <ce:figure id="fig6">
               <ce:label>Figure 6</ce:label>
               <ce:caption id="cap0045">
                  <ce:simple-para id="fspara0150" view="all">AKT Regulates Early TRAIL-Induced Apoptosis</ce:simple-para>
                  <ce:simple-para id="fspara0155" view="all">(A–F) IncuCyte-derived percentage cell death in wild-type, <ce:italic>BAX</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup>, <ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup>, and <ce:italic>XIAP</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> HCT116 cell lines over a 16-h time course. +AKTi treatments contained 27.6 μg/mL AKT1/2 kinase inhibitor; +TRAIL treatments, 50 ng/mL TRAIL; and +CHX treatments, 2.5μg/mL cycloheximide. Data in (A–F) represent means ± SD from three independent biological repeats taken at 30-min intervals. SDs are represented by shaded areas. For clarity, y axes (% cell death) are not all scaled to 100%. Treatments: (A) -AKTi -TRAIL –CHX, (B) -AKTi -TRAIL + CHX, (C) -AKTi + TRAIL + CHX, (D) +AKTi -TRAIL –CHX, (E) +AKTi -TRAIL + CHX, and (F) +AKTi + TRAIL + CHX.</ce:simple-para>
                  <ce:simple-para id="fspara0160" view="all">(G–Q) Time slices of A–F at 4- (G–J), 6- (K–M), and 8-h (N–Q) treatment, showing the effects of AKT inhibition across all TRAIL/CHX treatments. SDs here are represented by error bars. Asterisks above individual bars indicate values significantly different from wild-type within each treatment, whereas asterisks above lines spanning treatments indicate values from the same cell line that differ significantly between treatments. *p ≤ 0.05 (Welch two-sample t test); **p ≤ 0.01. Detailed statistical results are displayed in <ce:cross-ref refid="mmc2" id="crosref0650">Table S5</ce:cross-ref>.</ce:simple-para>
                  <ce:simple-para id="fspara0165" view="all">See also <ce:cross-ref refid="mmc1" id="crosref0655">Figures S2</ce:cross-ref> and <ce:cross-ref refid="mmc1" id="crosref0660">S3</ce:cross-ref>.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr6" xlink:type="simple" xlink:href="pii:S258900421930015X/gr6"/>
            </ce:figure>
         </ce:floats>
         <head>
            <ce:dochead id="dhead0010">
               <ce:textfn>Article</ce:textfn>
            </ce:dochead>
            <ce:title id="title0010">Mathematical Modeling Highlights the Complex Role of AKT in TRAIL-Induced Apoptosis of Colorectal Carcinoma Cells</ce:title>
            <ce:author-group id="augrp0010">
               <ce:author id="au1" orcid="0000-0003-3232-8652" author-id="S258900421930015X-bf9afe5e6225eb25660fa3e4ad4a7067">
                  <ce:given-name>Matthew W.</ce:given-name>
                  <ce:surname>Anderson</ce:surname>
                  <ce:cross-ref refid="aff1" id="crosref0010">
                     <ce:sup loc="post">1</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="fn1" id="crosref0015">
                     <ce:sup loc="post">4</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="cor1" id="crosref0020">
                     <ce:sup loc="post">∗</ce:sup>
                  </ce:cross-ref>
                  <ce:e-address type="email" xlink:href="mailto:m.w.anderson@exeter.ac.uk" id="eadd0010">m.w.anderson@exeter.ac.uk</ce:e-address>
               </ce:author>
               <ce:author id="au2" author-id="S258900421930015X-7e243ac20fdffaa28d9806732d0dbbf9">
                  <ce:given-name>Joanna J.</ce:given-name>
                  <ce:surname>Moss</ce:surname>
                  <ce:cross-ref refid="aff2" id="crosref0025">
                     <ce:sup loc="post">2</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au3" author-id="S258900421930015X-52ef3a7681d851e963461a65f44a6826">
                  <ce:given-name>Robert</ce:given-name>
                  <ce:surname>Szalai</ce:surname>
                  <ce:cross-ref refid="aff3" id="crosref0030">
                     <ce:sup loc="post">3</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="fn2" id="crosref0035">
                     <ce:sup loc="post">5</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au4" author-id="S258900421930015X-9f51f72df055ecc4674ca5f59a255fef">
                  <ce:given-name>Jon D.</ce:given-name>
                  <ce:surname>Lane</ce:surname>
                  <ce:cross-ref refid="aff2" id="crosref0040">
                     <ce:sup loc="post">2</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="fn2" id="crosref0045">
                     <ce:sup loc="post">5</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:affiliation id="aff1" affiliation-id="S258900421930015X-cff7a435d472d1656091b1bfbb46ed0d">
                  <ce:label>1</ce:label>
                  <ce:textfn>Centre for Biomedical Modelling and Analysis, Living Systems Institute, University of Exeter, Stocker Road, Exeter EX4 4QD, UK</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Centre for Biomedical Modelling and Analysis</sa:organization>
                     <sa:organization>Living Systems Institute</sa:organization>
                     <sa:organization>University of Exeter</sa:organization>
                     <sa:address-line>Stocker Road</sa:address-line>
                     <sa:city>Exeter</sa:city>
                     <sa:postal-code>EX4 4QD</sa:postal-code>
                     <sa:country>UK</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="aff2" affiliation-id="S258900421930015X-b9891f9638c4f2de15f228162836d488">
                  <ce:label>2</ce:label>
                  <ce:textfn>Cell Biology Laboratories, School of Biochemistry, University of Bristol, Medical Sciences Building, University Walk, Bristol BS8 1TD, UK</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Cell Biology Laboratories</sa:organization>
                     <sa:organization>School of Biochemistry</sa:organization>
                     <sa:organization>University of Bristol</sa:organization>
                     <sa:address-line>Medical Sciences Building</sa:address-line>
                     <sa:address-line>University Walk</sa:address-line>
                     <sa:city>Bristol</sa:city>
                     <sa:postal-code>BS8 1TD</sa:postal-code>
                     <sa:country>UK</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="aff3" affiliation-id="S258900421930015X-4c0cc0a59258df6d263e6f9c63d5b692">
                  <ce:label>3</ce:label>
                  <ce:textfn>Department of Engineering Mathematics, University of Bristol, Merchant Venturers Building, Woodland Road, Bristol BS8 1UB, UK</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Department of Engineering Mathematics</sa:organization>
                     <sa:organization>University of Bristol</sa:organization>
                     <sa:address-line>Merchant Venturers Building</sa:address-line>
                     <sa:address-line>Woodland Road</sa:address-line>
                     <sa:city>Bristol</sa:city>
                     <sa:postal-code>BS8 1UB</sa:postal-code>
                     <sa:country>UK</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:correspondence id="cor1">
                  <ce:label>∗</ce:label>
                  <ce:text>Corresponding author</ce:text>
               </ce:correspondence>
               <ce:footnote id="fn1">
                  <ce:label>4</ce:label>
                  <ce:note-para id="ntpara0010" view="all">Lead Contact</ce:note-para>
               </ce:footnote>
               <ce:footnote id="fn2">
                  <ce:label>5</ce:label>
                  <ce:note-para id="ntpara0015" view="all">These authors contributed equally</ce:note-para>
               </ce:footnote>
            </ce:author-group>
            <ce:date-received day="4" month="7" year="2018"/>
            <ce:date-revised day="13" month="12" year="2018"/>
            <ce:date-accepted day="8" month="1" year="2019"/>
            <ce:miscellaneous id="misc0010">Published: February 22, 2019</ce:miscellaneous>
            <ce:abstract id="abs0010" view="all" class="author">
               <ce:section-title id="sectitle0010">Summary</ce:section-title>
               <ce:abstract-sec id="abssec0010" view="all">
                  <ce:simple-para id="abspara0010" view="all">Protein kinase B/AKT is a highly connected protein involved in a range of signaling pathways. Although it is known to regulate several proteins in the apoptotic pathway, its system-level effects remain poorly understood. We investigated the dynamic interactions between AKT and key apoptotic proteins and constructed a deterministic ordinary differential equation protein interaction model of extrinsic apoptosis. Incorporating AKT and its indirect inhibitor, phosphatase and tensin homolog (PTEN), this was used to generate predictions of system dynamics. Using eigen analysis, we identified AKT and cytochrome <ce:italic>c</ce:italic> as the protein species most sensitive to perturbations. Cell death assays in Type II HCT116 colorectal carcinoma cells revealed a tendency toward Type I cell death behavior in the <ce:italic>XIAP</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> background, with cells displaying accelerated TRAIL-induced apoptosis. Finally, AKT inhibition experiments implicated AKT and not PTEN in influencing apoptotic proteins during early phases of TRAIL-induced apoptosis.</ce:simple-para>
               </ce:abstract-sec>
            </ce:abstract>
            <ce:abstract class="graphical" id="abs0015" view="all">
               <ce:section-title id="sectitle0015">Graphical Abstract</ce:section-title>
               <ce:abstract-sec id="abssec0015" view="all">
                  <ce:simple-para id="abspara0015" view="all">
                     <ce:display>
                        <ce:figure id="undfig1">
                           <ce:link locator="fx1" xlink:type="simple" xlink:href="pii:S258900421930015X/fx1"/>
                        </ce:figure>
                     </ce:display>
                  </ce:simple-para>
               </ce:abstract-sec>
            </ce:abstract>
            <ce:abstract class="author-highlights" id="abs0020" view="all">
               <ce:section-title id="sectitle0020">Highlights</ce:section-title>
               <ce:abstract-sec id="abssec0020" view="all">
                  <ce:simple-para id="abspara0020" view="all">
                     <ce:list id="ulist0010">
                        <ce:list-item id="u0010">
                           <ce:label>•</ce:label>
                           <ce:para id="p0010" view="all">TRAIL-induced apoptosis model describes AKT protein interaction dynamics</ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0015">
                           <ce:label>•</ce:label>
                           <ce:para id="p0015" view="all">AKT and cytochrome <ce:italic>c</ce:italic> identified as the proteins most sensitive to perturbations</ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0020">
                           <ce:label>•</ce:label>
                           <ce:para id="p0020" view="all">HCT116 cells shift from Type II to Type I cell death behavior in <ce:italic>XIAP</ce:italic>
                              <ce:sup loc="post">
                                 <ce:italic>−/−</ce:italic>
                              </ce:sup> background</ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0025">
                           <ce:label>•</ce:label>
                           <ce:para id="p0025" view="all">AKT and not PTEN influences early phases of TRAIL-induced apoptosis</ce:para>
                        </ce:list-item>
                     </ce:list>
                  </ce:simple-para>
               </ce:abstract-sec>
            </ce:abstract>
            <ce:abstract class="teaser" id="abs0025" view="all">
               <ce:abstract-sec id="abssec0025" view="all">
                  <ce:simple-para id="abspara0025" view="all">Cancer; Cell Biology; <ce:italic>In Silico</ce:italic> Biology</ce:simple-para>
               </ce:abstract-sec>
            </ce:abstract>
            <ce:keywords view="extended" xml:lang="en" id="kwrds0010" class="keyword">
               <ce:section-title id="sectitle0025">Subject Areas</ce:section-title>
               <ce:keyword id="kwrd0010">
                  <ce:text>Cancer</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0015">
                  <ce:text>Cell Biology</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0020">
                  <ce:text>
                     <ce:italic>In Silico</ce:italic> Biology</ce:text>
               </ce:keyword>
            </ce:keywords>
         </head>
         <body view="all">
            <ce:sections>
               <ce:section id="sec1" view="all">
                  <ce:section-title id="sectitle0030">Introduction</ce:section-title>
                  <ce:para id="p0030" view="all">Apoptosis is executed by caspases that are activated via intrinsic and extrinsic signaling pathways (<ce:cross-ref refid="bib46" id="crosref0050">Scaffidi et al., 1998</ce:cross-ref>). The intrinsic pathway is initiated by DNA damage, substrate detachment, or growth factor withdrawal and involves mitochondrial outer membrane permeabilization (MOMP), and the release of cytochrome <ce:italic>c</ce:italic> (<ce:cross-ref refid="bib24" id="crosref0055">Fulda and Debatin, 2006</ce:cross-ref>). The extrinsic pathway is induced by ligand binding to plasma membrane receptors of the tumor necrosis factor superfamily, and the downstream molecular cascade that is triggered is believed to be genetically determined. This pathway can trigger two types of cell death signaling. First, Type I cells such as lymphocytes undergo mitochondria-independent cell death, relying solely on a receptor or ligand-instigated caspase cascade (<ce:cross-refs refid="bib5 bib46" id="crosrefs0010">Barnhart et al., 2003; Scaffidi et al., 1998</ce:cross-refs>). In Type II cells, however, amplification through MOMP and cytochrome <ce:italic>c</ce:italic> release is necessary (<ce:cross-ref refid="bib46" id="crosref0060">Scaffidi et al., 1998</ce:cross-ref>). Understanding how specific cells coordinate apoptotic responses contributes to our appreciation of cell death dynamics in disease.</ce:para>
                  <ce:para id="p0035" view="all">AKT (protein kinase B) is a promiscuous serine/threonine-specific protein kinase that influences protein synthesis (<ce:cross-ref refid="bib57" id="crosref0065">Wu, 2013</ce:cross-ref>), proliferation (<ce:cross-ref refid="bib20" id="crosref0070">Dong et al., 2015</ce:cross-ref>), glucose metabolism (<ce:cross-ref refid="bib33" id="crosref0075">Kornfeld et al., 2013</ce:cross-ref>), synaptic signaling (<ce:cross-ref refid="bib38" id="crosref0080">Liu et al., 2015</ce:cross-ref>), autophagy (<ce:cross-refs refid="bib27 bib55" id="crosrefs0015">Heras-Sandoval et al., 2014; Wang et al., 2012</ce:cross-refs>), and nuclear factor-κB signaling (<ce:cross-ref refid="bib17" id="crosref0085">Davoudi et al., 2014</ce:cross-ref>). Several studies have also revealed a pivotal role for AKT in apoptosis. AKT inhibits apoptosis via inhibitory phosphorylation of the pro-apoptotic BCL-2 homology domain 3 (BH3-only) protein BAD (<ce:cross-ref refid="bib18" id="crosref0090">del Peso et al., 1997</ce:cross-ref>), triggering a cascade of inhibitory reactions impinging on pro-apoptotic BAX (AKT ┤ BAD ┤ BCL-2 ┤ BAX; ┤ denoting inhibition). The BCL-2-BAX and BAD-BCL-2 interactions are direct binding associations dependent on their respective BCL-2 homology (BH) domains, whereas AKT inactivates BAD through phosphorylation at Ser<ce:sup loc="post">136</ce:sup> leading to AKT sequestration by 14-3-3 proteins (<ce:cross-ref refid="bib18" id="crosref0095">del Peso et al., 1997</ce:cross-ref>). AKT also phosphorylates BAX at Ser<ce:sup loc="post">184</ce:sup>, preventing the conformational changes in BAX needed for oligomerization and pore-forming capabilities during MOMP (<ce:cross-ref refid="bib54" id="crosref0100">Wang et al., 2010</ce:cross-ref>). Downstream of MOMP, AKT phosphorylates procaspase-9 at Ser<ce:sup loc="post">196</ce:sup>, preventing its processing and activation (<ce:cross-ref refid="bib11" id="crosref0105">Cardone et al., 1998</ce:cross-ref>). It also phosphorylates the X-linked inhibitor of apoptosis protein (XIAP) (<ce:cross-ref refid="bib19" id="crosref0110">Deveraux and Reed, 1999</ce:cross-ref>), an E3 enzyme that ubiquitylates caspases 9, 3, and 7, targeting them for proteasomal degradation. XIAP also regulates its own stability through autoubiquitylation (<ce:cross-ref refid="bib41" id="crosref0115">Nakatani et al., 2013</ce:cross-ref>), a process that is blocked by AKT-mediated Ser<ce:sup loc="post">87</ce:sup> phosphorylation (<ce:cross-ref refid="bib16" id="crosref0120">Dan et al., 2004</ce:cross-ref>). Robust cell death initiation requires XIAP inhibition via SMAC (second mitochondria-derived activator of caspases) that is released during MOMP and binds to the tetrapeptide IAP-binding motif of XIAP (<ce:cross-ref refid="bib49" id="crosref0125">Scott et al., 2005</ce:cross-ref>). AKT phosphorylates SMAC at Ser<ce:sup loc="post">67</ce:sup> to increase its binding to XIAP, conferring resistance to apoptosis (<ce:cross-ref refid="bib31" id="crosref0130">Jeong et al., 2015</ce:cross-ref>).</ce:para>
                  <ce:para id="p0040" view="all">Any systems-level study of the role of AKT during apoptosis must consider PTEN (phosphatase and tensin homolog). PTEN acts as a positive regulator of apoptosis by antagonizing AKT activation (<ce:cross-ref refid="bib4" id="crosref0135">Baehrecke, 2005</ce:cross-ref>); however, it is also downregulated via XIAP-mediated ubiquitylation and degradation (<ce:cross-ref refid="bib52" id="crosref0140">Van Themsche et al., 2009</ce:cross-ref>). In this study, we have constructed a deterministic model of apoptosis incorporating the interactions between AKT, PTEN, and the apoptotic machinery. System dynamics predictions generated using this model describe how individual protein species as well as the apoptotic system as a whole are affected in different genetic backgrounds. This model accurately predicts protein dynamics for three of four HCT116 cell lines (wild-type; <ce:italic>BAX</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup>; <ce:italic>XIAP</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup>), and further investigations uncover the possible mechanisms behind the dynamics of the fourth (<ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup>). Subsequent laboratory studies show that AKT regulation of apoptosis is significantly stronger during TRAIL-mediated extrinsic apoptosis than in TRAIL-independent apoptosis in these cells, and that its effects are more prominent at early points in the apoptotic response.</ce:para>
               </ce:section>
               <ce:section id="sec2" view="all">
                  <ce:section-title id="sectitle0035">Results</ce:section-title>
                  <ce:section id="sec2.1" view="all">
                     <ce:section-title id="sectitle0040">The AKT Apoptosis Model Predicts Protein Dynamics in Different Genetic Backgrounds</ce:section-title>
                     <ce:para id="p0045" view="all">Using a simplified model of extrinsic apoptosis as a starting point (<ce:cross-ref refid="fig1" id="crosref0145">Figure 1</ce:cross-ref>
                        <ce:float-anchor refid="fig1"/>A), we constructed the AKT apoptosis model (AKTM) (<ce:cross-ref refid="fig1" id="crosref0150">Figure 1</ce:cross-ref>B), a deterministic, single-cell model wherein protein-protein interactions are described by ordinary differential equations and outputs report temporally variable protein concentrations (<ce:cross-ref refid="sec5" id="crosref0155">Methods</ce:cross-ref>). <ce:cross-ref refid="fig1" id="crosref0160">Figures 1</ce:cross-ref>C–1F are schematics depicting hypothesized effects of removing the influential proteins BAX, PTEN, XIAP, and AKT from the system, and the outcomes of AKTM simulations in these hypothetical scenarios are shown in <ce:cross-ref refid="fig2" id="crosref0165">Figure 2</ce:cross-ref>
                        <ce:float-anchor refid="fig2"/>.</ce:para>
                     <ce:para id="p0050" view="all">Simulated concentrations of active caspase-8 in all scenarios settled at or close to the same steady state by the end of the simulation. The first condition to reach steady state was <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> (∼8 h), followed by (1) <ce:italic>AKT</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> (∼10.8 h), (2) wild-type (∼11 h), (3) <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> (∼11.3 h), and (4) <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup>, which had not reached steady state by 16 h (<ce:cross-ref refid="fig2" id="crosref0170">Figure 2</ce:cross-ref>B). The active caspase-3 response curves did not settle at the same steady state, but instead reached peak concentrations at different magnitudes and times—the higher the peak, the earlier it occurred—in the following order: (1) <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> (∼7 h), (2) <ce:italic>AKT</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> (8 h), (3) wild-type (9 h), (4) <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> (10 h), and (5) <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> (12 h) (<ce:cross-ref refid="fig2" id="crosref0175">Figure 2</ce:cross-ref>C). Simulated concentrations of active caspase-3 were similar in <ce:italic>AKT</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> and <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> simulations, whereas they were ∼15% higher and ∼40% lower, respectively, in wild-type and <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> states (<ce:cross-ref refid="fig2" id="crosref0180">Figure 2</ce:cross-ref>C).</ce:para>
                     <ce:para id="p0055" view="all">Active BAX concentration peaked at ∼10 h in the wild-type simulation and at ∼8 h in <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup>, but required ∼16 h for <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> (<ce:cross-ref refid="fig2" id="crosref0185">Figure 2</ce:cross-ref>D). Peak active BAX concentration was similar in the wild-type and <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> simulations, but almost 30% lower in the absence of PTEN. The active BAX peak in the <ce:italic>AKT</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> simulation was approximately 50% higher than in wild-type, highlighting the AKT-imposed inhibition of BAX. Cytochrome <ce:italic>c</ce:italic> (<ce:cross-ref refid="fig2" id="crosref0190">Figure 2</ce:cross-ref>G) and SMAC (<ce:cross-ref refid="fig2" id="crosref0195">Figure 2</ce:cross-ref>H), the “products” of MOMP, are not released from the mitochondria in the absence of BAX and therefore never become cytosolic in the <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> simulation. Compared with wild-type, their release was slower in the <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> state, but faster in <ce:italic>AKT</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> and <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> scenarios. Cytoplasmic cytochrome <ce:italic>c</ce:italic> concentration settled at roughly the same steady state in these conditions (<ce:cross-ref refid="fig2" id="crosref0200">Figure 2</ce:cross-ref>G), but cytosolic SMAC concentration began to decay in the wild-type and <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> simulations (<ce:cross-ref refid="fig2" id="crosref0205">Figure 2</ce:cross-ref>H).</ce:para>
                     <ce:para id="p0060" view="all">In the <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> simulation, XIAP concentration did not begin to decay as quickly as in the other states, remaining the highest for the first 2–3 h until its decay speed increased (<ce:cross-ref refid="fig2" id="crosref0210">Figure 2</ce:cross-ref>J). Henceforth, XIAP concentration became greatest in the <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> state, eventually fully depleting in all simulations by the 6-h mark (<ce:cross-ref refid="fig2" id="crosref0215">Figure 2</ce:cross-ref>J). The <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> simulation also showed a comparatively large peak in active AKT concentration, evidence of the modeled AKT inhibition by PTEN (<ce:cross-ref refid="fig2" id="crosref0220">Figure 2</ce:cross-ref>K).</ce:para>
                     <ce:para id="p0065" view="all">The concentration-response curves for the aforementioned proteins are useful for understanding the underlying mechanisms governing system dynamics, but the overall apoptotic response is reported in the response curves for cleaved poly(ADP-ribose) polymerase (PARP) (<ce:cross-ref refid="fig2" id="crosref0225">Figure 2</ce:cross-ref>M). These presented the same sigmoid shape in each scenario, the only difference being the timing of the increase phase, which was initiated after 1 h in <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup>, 2.6 h in <ce:italic>AKT</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup>, 3.2 h in wild-type, 3.8 h in <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup>, and 5.7 h in <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup>. In all simulations, the increase phase lasted for ∼4.5 h, such that steady state was reached at 5.3 h in <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup>, 7.1 h in <ce:italic>AKT</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup>, 7.7 h in wild-type, 8.3 h in <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup>, and 10.2 h in <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> (<ce:cross-ref refid="fig2" id="crosref0230">Figure 2</ce:cross-ref>M).</ce:para>
                  </ce:section>
                  <ce:section id="sec2.2" view="all">
                     <ce:section-title id="sectitle0045">Eigen Analysis Reveals Perturbation Sensitivity of AKT and Cytochrome <ce:italic>c</ce:italic>
                     </ce:section-title>
                     <ce:para id="p0070" view="all">Eigen analysis was performed on the wild-type variant of the model, and of the 41 eigenvalues computed only three were positive at any point during the simulation. Positive eigenvalues indicate instability, and their corresponding eigenvectors represent the protein species whose relative concentrations have changed (<ce:cross-ref refid="sec5" id="crosref0235">Methods</ce:cross-ref>). The three positive eigenvalues are shown in <ce:cross-ref refid="fig3" id="crosref0240">Figures 3</ce:cross-ref>
                        <ce:float-anchor refid="fig3"/>A–3C, along with their corresponding most sensitive temporally variable protein species in <ce:cross-ref refid="fig3" id="crosref0245">Figures 3</ce:cross-ref>D–3F.</ce:para>
                     <ce:para id="p0075" view="all">Active AKT was identified as the protein species most sensitive to perturbations (<ce:cross-ref refid="fig3" id="crosref0250">Figure 3</ce:cross-ref>D, i), as calculated from eigenvalue 1 (<ce:cross-ref refid="fig3" id="crosref0255">Figure 3</ce:cross-ref>A) from the start of the simulation to a few minutes after the 3-h mark, the point at which AKT concentration peaked (<ce:cross-ref refid="fig2" id="crosref0260">Figure 2</ce:cross-ref>K). Subsequently, PARP governed model dynamics until 4.4 h (<ce:cross-ref refid="fig3" id="crosref0265">Figure 3</ce:cross-ref>D, ii), when cleaved PARP concentration reached a steady increase (<ce:cross-ref refid="fig2" id="crosref0270">Figure 2</ce:cross-ref>M). Cytosolic cytochrome <ce:italic>c</ce:italic> then became dominant, corresponding to the middle of its exponential phase in the simulation (<ce:cross-ref refid="fig2" id="crosref0275">Figure 2</ce:cross-ref>G). Finally, mitochondrial cytochrome <ce:italic>c</ce:italic> assumed responsibility at the 6-h mark (<ce:cross-ref refid="fig3" id="crosref0280">Figure 3</ce:cross-ref>D, iii), when the rate of increase in cytosolic cytochrome <ce:italic>c</ce:italic> began to become stable (<ce:cross-ref refid="fig2" id="crosref0285">Figure 2</ce:cross-ref>G). This was also the point at which the rate of increase in cleaved PARP concentration began to slow (<ce:cross-ref refid="fig2" id="crosref0290">Figure 2</ce:cross-ref>M). Mitochondrial cytochrome <ce:italic>c</ce:italic> maintained dominance of eigenvalue 1 dynamics until 8 h (<ce:cross-ref refid="fig3" id="crosref0295">Figure 3</ce:cross-ref>D, iv), when complete cell death had been reached (signified by the concentration of cleaved PARP reaching its maximum steady state [<ce:cross-ref refid="fig2" id="crosref0300">Figure 2</ce:cross-ref>M]).</ce:para>
                     <ce:para id="p0080" view="all">Eigenvalue 2 only became positive after 3.3 h when cleaved PARP was dominating its dynamics (<ce:cross-ref refid="fig3" id="crosref0305">Figure 3</ce:cross-ref>E, i). This continued until mitochondrial cytochrome <ce:italic>c</ce:italic> took over at 4.4 h (<ce:cross-ref refid="fig3" id="crosref0310">Figure 3</ce:cross-ref>E, ii) once the increase in cleaved PARP had become steady (<ce:cross-ref refid="fig2" id="crosref0315">Figure 2</ce:cross-ref>M) and the increase in the rate of release of mitochondrial cytochrome <ce:italic>c</ce:italic> was in its exponential phase (<ce:cross-ref refid="fig2" id="crosref0320">Figure 2</ce:cross-ref>G). The eigenvalue became negative at 5.1 h and could therefore not be regarded as unstable after this period. It did, however, become positive again for 0.2 h immediately before the 8-h mark, at which point cytosolic cytochrome <ce:italic>c</ce:italic> governed its dynamics (<ce:cross-ref refid="fig3" id="crosref0325">Figure 3</ce:cross-ref>E, iii). Taken together with eigenvalue 1, the period from 4.4–8 h is dominated by cytochrome <ce:italic>c</ce:italic> release dynamics as it is largely the mitochondrial and cytosolic cytochrome <ce:italic>c</ce:italic> species that control the dynamics of eigenvalues 1 and 2 during this period.</ce:para>
                     <ce:para id="p0085" view="all">Eigenvalue 3 also only became positive after 3.3 h, at which point cytosolic cytochrome <ce:italic>c</ce:italic> was dominating its dynamics (<ce:cross-ref refid="fig3" id="crosref0330">Figure 3</ce:cross-ref>F, i). At the 4.4-h mark, cleaved PARP briefly (∼2 min) took over (<ce:cross-ref refid="fig3" id="crosref0335">Figure 3</ce:cross-ref>F, ii), before PARP assumed greater responsibility for eigenvalue 3 dynamics until 5.1 h, while it was still positive (<ce:cross-ref refid="fig3" id="crosref0340">Figures 3</ce:cross-ref>F, iii). The eigenvalue was then negative for the remainder of the simulation, and there are no other positive eigenvalues to identify. In addition to the sensitivity to perturbations of cytochrome <ce:italic>c</ce:italic> revealed by eigenvalues 1 and 2, eigenvalue 3 highlights the sensitivity of PARP, but only until MOMP transition initiated (i.e., the point of no return).</ce:para>
                  </ce:section>
                  <ce:section id="sec2.3" view="all">
                     <ce:section-title id="sectitle0050">Cell Death Assays Validate AKTM Predictions</ce:section-title>
                     <ce:para id="p0090" view="all">We next tested the accuracy of our model <ce:italic>in vitro</ce:italic> using <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup>, <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup>, and <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> HCT116 cell lines. <ce:cross-ref refid="fig4" id="crosref0345">Figure 4</ce:cross-ref>
                        <ce:float-anchor refid="fig4"/> shows cell death assay results represented as percentage cell death for control/untreated (<ce:cross-ref refid="fig4" id="crosref0350">Figures 4</ce:cross-ref>A), 2.5 μg/mL cycloheximide (CHX)-treated (<ce:cross-ref refid="fig4" id="crosref0355">Figure 4</ce:cross-ref>B), and 50 ng/mL TRAIL + 2.5 μg/mL CHX-treated cells (<ce:cross-ref refid="fig4" id="crosref0360">Figure 4</ce:cross-ref>C). As expected, TRAIL + CHX (<ce:cross-ref refid="fig4" id="crosref0365">Figure 4</ce:cross-ref>C) caused the highest cell death: by the end of the 16-h imaging period all cells were dead in the <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> and <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> lines, whereas cell death in the <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> (83.4% ± 2.8%) and wild-type (95.1% ± 2.1%) lines was marginally delayed. Time taken to achieve 50% cell death was also recorded for these treatments (<ce:cross-ref refid="fig4" id="crosref0370">Figure 4</ce:cross-ref>D), demonstrating significantly delayed apoptosis in the <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup>line and significantly advanced apoptosis in the <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> line. There was no significant difference between the <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> and wild-type lines.</ce:para>
                     <ce:para id="p0095" view="all">The most obvious (although minor) discrepancy between simulation and experimental data was seen in the <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> line. Here, the model predicted a slight delay in the onset of apoptosis, whereas the data reported an advanced apoptotic onset, despite similar time to 50% cell death recordings (<ce:cross-ref refid="fig4" id="crosref0375">Figure 4</ce:cross-ref>D). This may be due to inaccurate model parameterization; however, we chose to investigate this further through protein quantification.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.4" view="all">
                     <ce:section-title id="sectitle0055">Absence of BAX Expression in <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> HCT116 Cells</ce:section-title>
                     <ce:para id="p0100" view="all">Immunoblotting was performed on the wild-type, <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup>, <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup>, and <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> HCT116 cell lines using antibodies against AKT, p-AKT Ser<ce:sup loc="post">473</ce:sup>, PTEN, XIAP, and BAX (tubulin was used as a loading control) (<ce:cross-ref refid="fig5" id="crosref0380">Figure 5</ce:cross-ref>
                        <ce:float-anchor refid="fig5"/>A). AKT levels in the three knockout cell lines were similar to those in wild-type (<ce:cross-ref refid="fig5" id="crosref0385">Figure 5</ce:cross-ref>B). The same was true for p-AKT Ser<ce:sup loc="post">473</ce:sup> in the <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">−/−</ce:sup> and <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">−/−</ce:sup> lines, but p-AKT Ser<ce:sup loc="post">473</ce:sup> was significantly higher in the <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> line compared with the wild-type (p &lt; 0.05; <ce:cross-ref refid="fig5" id="crosref0390">Figure 5</ce:cross-ref>C), as would be expected with no PTEN-imposed AKT inhibition. The PTEN level in the <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> line did not differ significantly from wild-type, but it was significantly higher in the <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> line (p &lt; 0.05; <ce:cross-ref refid="fig5" id="crosref0395">Figure 5</ce:cross-ref>D), consistent with its role in stimulating PTEN degradation (<ce:cross-ref refid="bib52" id="crosref0400">Van Themsche et al., 2009</ce:cross-ref>). XIAP levels did not differ between the <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> and <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> lines (<ce:cross-ref refid="fig5" id="crosref0405">Figure 5</ce:cross-ref>E). Surprisingly, however, BAX was not detected in the <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> line (<ce:cross-ref refid="fig5" id="crosref0410">Figure 5</ce:cross-ref>F). To further examine this unexpected finding, we first carried out qRT-PCR to measure BAX mRNA levels in the <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> line. BAX mRNA was detected at the same level in wild-type and <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> cells (<ce:cross-ref refid="fig5" id="crosref0415">Figure 5</ce:cross-ref>H), arguing that the absence of BAX protein in <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> cells was not due to impaired transcription. Treatment with inhibitors of proteasomal (MG132) and/or lysosomal (bafilomycin A1) degradation did not restore BAX protein levels in <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> cells, suggesting that the absence of BAX was not caused by rapid protein degradation (data not shown). Furthermore, immunoprecipitation suggested the absence of any interaction between PTEN and BAX in wild-type HCT116 cells (<ce:cross-ref refid="fig5" id="crosref0420">Figure 5</ce:cross-ref>J), arguing that PTEN does not help to stabilize BAX under normal conditions. This was further corroborated by small interfering RNA (siRNA)-mediated silencing of PTEN in wild-type HCT116 cells, as suppression of PTEN expression did not lead to reduced levels of BAX (<ce:cross-ref refid="fig5" id="crosref0425">Figure 5</ce:cross-ref>K).</ce:para>
                     <ce:para id="p0105" view="all">In the light of the observed absence of BAX in the <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> HCT116 line, it should subsequently be considered as both PTEN and BAX deficient. Additional modeling was therefore performed to simulate the lack of BAX in the <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> background (<ce:italic>BAX/PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup>; <ce:cross-ref refid="mmc1" id="crosref0430">Figure S1</ce:cross-ref>). Rather than generating a cleaved PARP concentration-response curve that matched the <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> scenario, this model reported a response curve that was almost identical to <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> (<ce:cross-ref refid="mmc1" id="crosref0435">Figure S1</ce:cross-ref>A). The <ce:italic>BAX/PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> response curves for the majority of other protein species also matched <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> (data not shown), with the following exceptions: the active AKT curve increased in line with <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> but instead of peaking and falling to a lower steady state, it continued rising to an approximately 3-fold higher steady state (<ce:cross-ref refid="mmc1" id="crosref0440">Figure S1</ce:cross-ref>B); the XIAP curve began following the trajectory of <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup>, but converged with <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> at the 6-h mark (<ce:cross-ref refid="mmc1" id="crosref0445">Figure S1</ce:cross-ref>C).</ce:para>
                  </ce:section>
                  <ce:section id="sec2.5" view="all">
                     <ce:section-title id="sectitle0060">AKT Regulates Early TRAIL-Induced Apoptosis</ce:section-title>
                     <ce:para id="p0110" view="all">To complement the modeling data, we next focused on AKT and its temporally variable effects on apoptosis using an IncuCyte imaging system. Wild-type and homozygous knockout HCT116 cells were treated with an AKT1/2 inhibitor (AKTi), in combination with TRAIL and/or CHX (<ce:cross-ref refid="fig6" id="crosref0450">Figure 6</ce:cross-ref>
                        <ce:float-anchor refid="fig6"/>: panels A–F show cell death over a 16-h time course; panels G–Q show time-slice data at 4, 6, and 8 h). Immunoblotting provided evidence for increased AKT activity following TRAIL treatment, as measured by increased p-AKT Ser<ce:sup loc="post">473</ce:sup> levels, and demonstrated that the AKTi was effective (<ce:cross-ref refid="mmc1" id="crosref0455">Figure S2</ce:cross-ref>).</ce:para>
                     <ce:para id="p0115" view="all">Basal cell death rates were highest in the <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> line in the absence or presence of AKTi, and lowest in the <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> line (<ce:cross-ref refid="fig6" id="crosref0460">Figures 6</ce:cross-ref>A, 6D, 6G, 6K, and 6N). Variation from wild-type was recorded for the <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> line in the absence of AKTi (significantly higher at 4 and 8 h in the absence of AKTi; <ce:cross-ref refid="fig6" id="crosref0465">Figures 6</ce:cross-ref>G and 6N), and for <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> (significantly lower at 4 and 6 h with AKTi; <ce:cross-ref refid="fig6" id="crosref0470">Figures 6</ce:cross-ref>G and 6K). Inclusion of CHX (<ce:cross-ref refid="fig6" id="crosref0475">Figures 6</ce:cross-ref>B, 6E, 6H, 6L, and 6P) caused a 4- to 5-fold increase in basal cell death kinetics across all cell lines (relative to untreated cells; compare <ce:cross-ref refid="fig6" id="crosref0480">Figures 6</ce:cross-ref>A and 6D with <ce:cross-ref refid="fig6" id="crosref0485">Figures 6</ce:cross-ref>B and 6E). The <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> line again displayed the most rapid cell death kinetics, and the <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> line the slowest, although in the absence of AKTi, <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> cell death was significantly greater than wild-type only at the 8-h mark (<ce:cross-ref refid="fig6" id="crosref0490">Figure 6</ce:cross-ref>P). In the presence of CHX and AKTi, cell death was significantly higher in <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> than wild-type cells (6 h; <ce:cross-ref refid="fig6" id="crosref0495">Figure 6</ce:cross-ref>L), and lower in <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> cells (6 and 8 h; <ce:cross-ref refid="fig6" id="crosref0500">Figures 6</ce:cross-ref>L and 6P). AKT inhibition in CHX-treated cells altered cell death responses only in the <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> line at the 6-h mark (significantly higher; <ce:cross-ref refid="fig6" id="crosref0505">Figure 6</ce:cross-ref>L).</ce:para>
                     <ce:para id="p0120" view="all">Treatments with both CHX and TRAIL (<ce:cross-ref refid="fig6" id="crosref0510">Figures 6</ce:cross-ref>C and 6F) generated considerably higher levels of cell death in all cell lines, as anticipated. Cell death levels differed significantly from wild-type across all time points in both the <ce:italic>BAX</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> (lower in the absence and presence of AKTi) and <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> (higher in the absence of AKTi). In the <ce:italic>XIAP</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> line in the presence of AKTi, cell death was significantly higher than wild-type only at the 6-h point as cell death approached 100% for both conditions (<ce:cross-ref refid="fig6" id="crosref0515">Figure 6</ce:cross-ref>M). Of note, AKT inhibition increased cell death rates most effectively in TRAIL/CHX-treated cells, and this was especially apparent at the 4- and 6-h points (<ce:cross-ref refid="fig6" id="crosref0520">Figures 6</ce:cross-ref>J and 6M).</ce:para>
                     <ce:para id="p0125" view="all">An important finding from these cell death experiments was that cell death in the <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> line did not differ significantly from that of wild-type under any condition (despite these cells apparently lacking BAX; <ce:cross-ref refid="fig5" id="crosref0525">Figures 5</ce:cross-ref>A and 5F). Furthermore, there were no instances wherein AKT inhibition significantly altered cell death rates in the <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> line, arguing that PTEN has a negligible influence over cell death dynamics during TRAIL-induced apoptosis. In support of this, cell death analysis by caspase activity in cells transfected with GFP, wild-type PTEN, or catalytically inactive C124S PTEN (<ce:cross-ref refid="bib40" id="crosref0530">Myers et al., 1997</ce:cross-ref>) suggested that overexpression of PTEN in active or inactive forms did not alter apoptosis kinetics in cells treated with TRAIL (<ce:cross-ref refid="mmc1" id="crosref0535">Figure S3</ce:cross-ref>).</ce:para>
                  </ce:section>
               </ce:section>
               <ce:section id="sec3" view="all">
                  <ce:section-title id="sectitle0065">Discussion</ce:section-title>
                  <ce:para id="p0130" view="all">Mathematical modeling can be used to generate predictions of how complex systems, such as apoptosis, behave under different conditions. Here, we have constructed a simplified model to describe the dynamics of the extrinsic apoptotic pathway with sufficient accuracy to provide a framework to test predictions in the laboratory. Using cleaved PARP concentration as an indicator of apoptosis (<ce:cross-ref refid="fig2" id="crosref0540">Figure 2</ce:cross-ref>M), the model behaved as predicted for both the removal of BAX and XIAP, with a delayed and hastened onset of apoptosis, respectively. These predictions were based on the same <ce:italic>BAX</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> HCT116 cell line used in this study having previously been used to demonstrate a delayed—albeit not abolished—apoptotic response (<ce:cross-refs refid="bib60 bib53" id="crosrefs0020">Zhang et al., 2000; Wang and Youle, 2012</ce:cross-refs>), and the <ce:italic>XIAP</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> HCT116 cell line having demonstrated the opposite (<ce:cross-ref refid="bib15" id="crosref0545">Cummins et al., 2004</ce:cross-ref>). The model did not, however, simulate the large expected delay in onset for the removal of PTEN. This expectation was based on the known role of PTEN as a tumor suppressor (<ce:cross-refs refid="bib37 bib36" id="crosrefs0025">Li et al., 1997; Lee et al., 2004</ce:cross-refs>). To our knowledge, the <ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> HCT116 cell line has not previously been used for the purpose of this study.</ce:para>
                  <ce:para id="p0135" view="all">Using TRAIL as a death-inducing ligand, cell death kinetics very closely resembled the sigmoid-shaped curves of cleaved PARP concentration from the simulation (<ce:cross-ref refid="fig2" id="crosref0550">Figure 2</ce:cross-ref>M). More specifically, the <ce:italic>BAX</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> and <ce:italic>XIAP</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> cell lines responded as predicted by the model, with a later onset and earlier onset of cell death, respectively. HCT116 cells are known to be Type II cells (<ce:cross-refs refid="bib6 bib2 bib25 bib30" id="crosrefs0030">Bentele et al., 2004; Aldridge et al., 2011; Gillissen et al., 2013; Huang et al., 2016</ce:cross-refs>), and several studies have suggested that whether a cell follows this behavior or that of Type I depends largely on the relative concentrations of various key apoptotic proteins (<ce:cross-refs refid="bib2 bib25 bib46" id="crosrefs0035">Aldridge et al., 2011; Gillissen et al., 2013; Scaffidi et al., 1998</ce:cross-refs>). In Type II cells, caspase-8 does not activate sufficient caspase-3 to trigger apoptosis, largely due to the overwhelming concentration of XIAP, meaning that amplification through BAX-mediated MOMP is needed (<ce:cross-ref refid="bib46" id="crosref0555">Scaffidi et al., 1998</ce:cross-ref>). <ce:cross-ref refid="bib2" id="crosref0560">Aldridge et al. (2011)</ce:cross-ref> showed that the defining factor for Type II cells is a high XIAP to caspase-3 concentration ratio, but that there might also be other factors involved such as the efficiency of caspase-8-mediated BID cleavage (<ce:cross-ref refid="bib42" id="crosref0565">Özören and El-Deiry, 2002</ce:cross-ref>). Some studies have also shown that within a single cell line, genetic or pharmacological manipulation affecting the expression of certain proteins—such as XIAP or BAX/BAK—can cause Type II cells to adapt to Type I behavior, and that the extent to which this occurs is concentration dependent rather than being a binary switch between the two (<ce:cross-refs refid="bib2 bib25" id="crosrefs0040">Aldridge et al., 2011; Gillissen et al., 2013</ce:cross-refs>).</ce:para>
                  <ce:para id="p0140" view="all">In the present study, the removal of BAX from the system slowed down the onset of apoptosis, but did not prevent it entirely. This may be in part due to the cells adapting to more of a Type I behavior, and it may also be partly because these cells were only <ce:italic>BAX</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> and not double <ce:italic>BAX/BAK</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> (required to fully disable the mitochondrial apoptotic pathway; <ce:cross-ref refid="bib60" id="crosref0570">Zhang et al., 2000</ce:cross-ref>). In the absence of XIAP, the very rapid apoptotic response suggests that these cells are reverting to Type I. Indeed, <ce:cross-ref refid="bib25" id="crosref0575">Gillissen et al. (2013)</ce:cross-ref> showed that silencing XIAP led to mitochondria-independent cell death (Type I) in <ce:italic>BAX/BAK</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> HCT116 cells.</ce:para>
                  <ce:para id="p0145" view="all">The <ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> line, however, did not match model predictions, having an earlier onset similar to the <ce:italic>XIAP</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> line. This is counterintuitive, as PTEN is an indirect inhibitor of AKT, which itself is an inhibitor of apoptosis. Strikingly, BAX protein was found to be missing in the <ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> line (<ce:cross-ref refid="fig5" id="crosref0580">Figures 5</ce:cross-ref>A and 5F), although surprisingly its transcript was present at control levels. Further analysis of BAX stability in <ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> cells treated with proteasomal and/or lysosomal inhibitors suggested that the absence of BAX protein was not due to enhanced turnover. In addition, siRNA silencing of PTEN expression in wild-type HCT116 cells was not associated with a marked reduction in BAX, arguing against direct causality between PTEN expression and BAX protein levels. Taken together, our data imply that some other form of post-transcriptional regulation of BAX in these cells is resulting in its absence.</ce:para>
                  <ce:para id="p0150" view="all">According to both the model and the experimental data, the absence of BAX should cause a substantial delay in apoptotic onset, yet this was not observed in the <ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> line. Additional modeling of a hypothetical BAX/<ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> cell line produced a cleaved PARP response curve almost identical to that of the <ce:italic>BAX</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> line (<ce:cross-ref refid="mmc1" id="crosref0585">Figure S1</ce:cross-ref>), showing that the current model cannot fully explain this anomaly. This additional modeling does, however, suggest that PTEN has some influence on XIAP early in the apoptotic response and on AKT throughout, but this is still not sufficient to significantly affect the overall apoptotic dynamics. In the model, the <ce:italic>BAX/PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> response curve for cleaved PARP behaves as <ce:italic>BAX</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup>, suggesting a much stronger influence of BAX than PTEN on the system. As the percentage of cell death in the <ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> cell line did not significantly differ from that in the wild-type, the absence of BAX in this background is less influential. This could imply XIAP-imposed compensatory regulation on the <ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> system, because free XIAP levels are likely to be higher in the absence of one of its substrates (PTEN), as the model suggests (<ce:cross-ref refid="fig2" id="crosref0590">Figure 2</ce:cross-ref>J). This was not, however, reflected in the total XIAP levels (<ce:cross-ref refid="fig5" id="crosref0595">Figure 5</ce:cross-ref>E). Overall, this is indicative of the noise that can often be introduced when attempting to characterize a nonlinear complex system.</ce:para>
                  <ce:para id="p0155" view="all">Eigenanalysis of the wild-type model revealed AKT, cytochrome <ce:italic>c,</ce:italic> and PARP as the protein species most sensitive to perturbations. The mitochondrial release of cytochrome <ce:italic>c</ce:italic> marks the point of no return in a dying cell and PARP cleavage is the ultimate readout of the model, whereas AKT acts on the system before MOMP and was therefore a good candidate to manipulate experimentally. Investigating AKT dynamics also proved interesting from a modeling perspective because the removal of AKT predicted a large increase in active BAX concentration (<ce:cross-ref refid="fig2" id="crosref0600">Figure 2</ce:cross-ref>D) and advanced cytochrome <ce:italic>c</ce:italic> mitochondrial release similar to the <ce:italic>XIAP</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> simulation (<ce:cross-ref refid="fig2" id="crosref0605">Figure 2</ce:cross-ref>G), yet minor advancement in the cleavage of PARP (<ce:cross-ref refid="fig2" id="crosref0610">Figure 2</ce:cross-ref>M).</ce:para>
                  <ce:para id="p0160" view="all">In subsequent live-cell imaging experiments, AKT inhibition advanced cell death to the greatest extent during early TRAIL-dependent apoptosis, but did so in all cell lines except <ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> (<ce:cross-ref refid="fig6" id="crosref0615">Figure 6</ce:cross-ref>). In addition, <ce:italic>PTEN</ce:italic>
                     <ce:sup loc="post">
                        <ce:italic>−/−</ce:italic>
                     </ce:sup> cells did not differ significantly from wild-type under any treatment, despite their lax of BAX protein. In addition to the possible XIAP-imposed compensatory effect proposed earlier, the inherent interconnectivity of AKT in numerous cellular signaling pathways might explain this unexpected finding. It is possible that one or more of the myriad interactions between AKT and other signaling pathways are causing compensatory effects in the absence of PTEN, resulting in variability in the very nature of the apoptotic regulatory mechanisms of AKT. Pursuing an answer to this question represents a prime example of how the numerous potential protein interactions inherent to the study of complex systems require an interdisciplinary approach.</ce:para>
                  <ce:section id="sec3.1" view="all">
                     <ce:section-title id="sectitle0070">Limitations of the Study</ce:section-title>
                     <ce:para id="p0165" view="all">An obvious limitation of any experimental work that uses cell lines in culture is whether a given cell type is representative of its tissue of origin or cells in general. This is particularly true for transformed cells derived from human tumors, for example, that accumulate specific mutations likely to alter their cell growth and/or cell death kinetics. Although in this case our computer-based model has been able to predict with some accuracy the cell death kinetics of a cell line in culture (in this case, HCT116 cells)—arguing that there is a reasonable level of functional plasticity in the mode—it is unlikely that such a predictive system would be applicable to all cells. There is direct evidence for this in our comparisons of predictive and actual cell death kinetics in the <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> cell line. With respect to this cell line, as we were unable to identify the precise mechanism behind the absence of BAX protein in <ce:italic>PTEN</ce:italic>
                        <ce:sup loc="post">
                           <ce:italic>−/−</ce:italic>
                        </ce:sup> cells, we must also consider the use of this cell line as a limitation of the study.</ce:para>
                  </ce:section>
               </ce:section>
               <ce:section id="sec5" role="materials-methods" view="all">
                  <ce:section-title id="sectitle0080">Methods</ce:section-title>
                  <ce:para id="p0175" view="all">All methods can be found in the accompanying <ce:cross-ref refid="mmc1" id="crosref0620">Transparent Methods supplemental file</ce:cross-ref>.</ce:para>
               </ce:section>
            </ce:sections>
            <ce:acknowledgment id="ack0010" view="all">
               <ce:section-title id="sectitle0085">Acknowledgments</ce:section-title>
               <ce:para id="p0180a" view="all">We thank Bree Aldridge and John Albeck for their previous work and useful modeling discussions, Alexander Greenhough and Bert Vogelstein for the provision of cell lines, Emma Vincent for advice and reagents, Tilo Burghardt for advice on image analysis, and members of the Lane laboratory for comments on experimental development. In particular, we would like to thank Dr. Lucy Crompton for assistance with the qRT-PCR and caspase assays. This work was supported primarily by the <ce:grant-sponsor id="gs1" sponsor-id="https://doi.org/10.13039/501100000266" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">EPSRC</ce:grant-sponsor> (<ce:grant-number refid="gs1">EP/I013717/1</ce:grant-number>), with much of the analysis and writing generously supported by the <ce:grant-number refid="gs1">Wellcome Trust</ce:grant-number> Institutional Strategic Support Award (204909/Z/16/Z).</ce:para>
               <ce:section id="sec6" role="contributing" view="all">
                  <ce:section-title id="sectitle0090">Author Contributions</ce:section-title>
                  <ce:para id="p0185" view="all">M.W.A. and R.S. developed the model; M.W.A., J.J.M., and J.D.L. designed the experiments and collected data; and M.W.A. developed image analysis software and ran model simulations and analyses. All authors wrote the paper.</ce:para>
               </ce:section>
               <ce:section id="sec7" role="conflict-of-interest" view="all">
                  <ce:section-title id="sectitle0095">Declaration of Interests</ce:section-title>
                  <ce:para id="p0190" view="all">The authors declare no competing interests.</ce:para>
               </ce:section>
            </ce:acknowledgment>
            <ce:appendices view="all">
               <ce:section id="appsec3" view="all">
                  <ce:section-title id="sectitle0110b">Data and Software Availibility</ce:section-title>
                  <ce:para id="p0180" view="all">Raw data for the cell death assays (<ce:cross-ref refid="fig4" id="crosref0665">Figure 4</ce:cross-ref>), Western blot quantification (<ce:cross-ref refid="fig5" id="crosref0670">Figure 5</ce:cross-ref>), and AKT inhibition experiments (<ce:cross-ref refid="fig6" id="crosref0675">Figure 6</ce:cross-ref>) are available online via a Mendeley Data repository with DOI links as follows: Cell death assays (<ce:cross-ref refid="fig4" id="crosref0680">Figure 4</ce:cross-ref>): <ce:inter-ref xlink:href="doi:10.17632/hvwswmgg7p.1" id="intref9010" xlink:type="simple">https://doi.org/10.17632/hvwswmgg7p.1</ce:inter-ref> Western blot quantification (<ce:cross-ref refid="fig5" id="crosref0685">Figure 5</ce:cross-ref>): <ce:inter-ref xlink:href="doi:10.17632/x8v9937psj.1" id="intref8010c" xlink:type="simple">https://doi.org/10.17632/x8v9937psj.1</ce:inter-ref> AKT inhibition experiments (<ce:cross-ref refid="fig6" id="crosref0690">Figure 6</ce:cross-ref>): <ce:inter-ref xlink:href="doi:10.17632/74pf4wwdd4.1" id="intref8010" xlink:type="simple">https://doi.org/10.17632/74pf4wwdd4.1</ce:inter-ref>.</ce:para>
               </ce:section>
               <ce:section id="appsec1" view="compact-standard">
                  <ce:section-title id="sectitle0100">Supplemental Information</ce:section-title>
                  <ce:para id="p0195" view="all">Supplemental Information includes Transparent Methods, three figures, five tables, and one data file and can be found with this article online at <ce:inter-ref xlink:href="doi:10.1016/j.isci.2019.01.015" id="intref0010" xlink:type="simple">https://doi.org/10.1016/j.isci.2019.01.015</ce:inter-ref>.</ce:para>
               </ce:section>
               <ce:section id="appsec2" view="extended">
                  <ce:section-title id="sectitle0105">Supplemental Information</ce:section-title>
                  <ce:para id="p0200" view="all">
                     <ce:display>
                        <ce:e-component id="mmc1">
                           <ce:label>Document S1. Transparent Methods, Figures S1–S3, and Tables S1–S4</ce:label>
                           <ce:link locator="mmc1" xlink:type="simple" xlink:href="pii:S258900421930015X/mmc1"/>
                        </ce:e-component>
                     </ce:display>
                     <ce:display>
                        <ce:e-component id="mmc2">
                           <ce:label>Table S5. Statistical Results, Related to Figures 4–6</ce:label>
                           <ce:caption id="cap0010">
                              <ce:simple-para id="espara0015" view="all">Significant results are presented with asterisks (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001). t values and degrees of freedom (df) are shown to 2 decimal places (d.p.) and p values to 5 d.p. Quantification of immunoblots for <ce:cross-ref refid="fig5" id="crosref0625">Figure 5</ce:cross-ref> were performed after normalizing the wild-type cell line to 1. Where t values are -Inf (negative infinity) with p values of 2.2 ×e<ce:sup loc="post">−16</ce:sup>, these are all cases where three independent biological repeats of zero (with therefore zero SD) are tested against the wild-type cell line (equal to 1). One-tailed t tests were used for <ce:cross-ref refid="fig5" id="crosref0630">Figure 5</ce:cross-ref>, and Welch two-sample t tests were used in all other cases.</ce:simple-para>
                           </ce:caption>
                           <ce:link locator="mmc2" xlink:type="simple" xlink:href="pii:S258900421930015X/mmc2"/>
                        </ce:e-component>
                     </ce:display>
                     <ce:display>
                        <ce:e-component id="mmc3">
                           <ce:label>Data S1. MATLAB Code Files, Related to Figures 1–3</ce:label>
                           <ce:caption id="cap0015">
                              <ce:simple-para id="espara0025" view="all">ZIP file containing all MATLAB code files required to run and analyze the model. Files include <ce:italic>NEWintegrate_DLE,</ce:italic> runs the model by calling the following files; <ce:italic>NEWinitials,</ce:italic> the model's initial conditions; <ce:italic>NEWrates2,</ce:italic> the model's reaction rate constants; NEWdegrhsVRoff2, the function containing all of the model's ODEs; and <ce:italic>NEWeigenanal,</ce:italic> eigenanalysis file (not called by <ce:italic>NEWintegrate_DLE</ce:italic>).</ce:simple-para>
                           </ce:caption>
                           <ce:link locator="mmc3" xlink:type="simple" xlink:href="pii:S258900421930015X/mmc3"/>
                        </ce:e-component>
                     </ce:display>
                  </ce:para>
               </ce:section>
            </ce:appendices>
         </body>
         <tail view="all">
            <ce:bibliography id="cebib0010" view="all">
               <ce:section-title id="sectitle0110">References</ce:section-title>
               <ce:bibliography-sec id="cebibsec0010" view="all">
                  <ce:bib-reference id="bib2">
                     <ce:label>Aldridge et al., 2011</ce:label>
                     <sb:reference id="sref2">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.B.</ce:given-name>
                                 <ce:surname>Aldridge</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Gaudet</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.A.</ce:given-name>
                                 <ce:surname>Lauffenburger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.K.</ce:given-name>
                                 <ce:surname>Sorger</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Lyapunov exponents and phase diagrams reveal multi-factorial control over TRAIL-induced apoptosis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mol. Syst. Biol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>7</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>553</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib4">
                     <ce:label>Baehrecke, 2005</ce:label>
                     <sb:reference id="sref4">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>E.H.</ce:given-name>
                                 <ce:surname>Baehrecke</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Autophagy: dual roles in life and death?</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Rev. Mol. Cell Biol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>6</sb:volume-nr>
                              </sb:series>
                              <sb:date>2005</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>505</sb:first-page>
                              <sb:last-page>510</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib5">
                     <ce:label>Barnhart et al., 2003</ce:label>
                     <sb:reference id="sref5">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.C.</ce:given-name>
                                 <ce:surname>Barnhart</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.C.</ce:given-name>
                                 <ce:surname>Alappat</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.E.</ce:given-name>
                                 <ce:surname>Peter</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The CD95 type I/type II model</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:edited-book>
                              <sb:editors>
                                 <sb:editor>
                                    <ce:given-name>D.R.</ce:given-name>
                                    <ce:surname>Green</ce:surname>
                                 </sb:editor>
                              </sb:editors>
                              <sb:book-series>
                                 <sb:series>
                                    <sb:title>
                                       <sb:maintitle>Seminars in Immunology</sb:maintitle>
                                    </sb:title>
                                    <sb:volume-nr>Vol. 15</sb:volume-nr>
                                 </sb:series>
                              </sb:book-series>
                              <sb:date>2003</sb:date>
                              <sb:publisher>
                                 <sb:name>Academic Press</sb:name>
                              </sb:publisher>
                           </sb:edited-book>
                           <sb:pages>
                              <sb:first-page>185</sb:first-page>
                              <sb:last-page>193</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib6">
                     <ce:label>Bentele et al., 2004</ce:label>
                     <sb:reference id="sref6">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Bentele</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Lavrik</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ulrich</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Stösser</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.W.</ce:given-name>
                                 <ce:surname>Heermann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Kalthoff</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.H.</ce:given-name>
                                 <ce:surname>Krammer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Eils</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Cell Biol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>166</sb:volume-nr>
                              </sb:series>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>839</sb:first-page>
                              <sb:last-page>851</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib11">
                     <ce:label>Cardone et al., 1998</ce:label>
                     <sb:reference id="sref11">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.H.</ce:given-name>
                                 <ce:surname>Cardone</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Roy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.R.</ce:given-name>
                                 <ce:surname>Stennicke</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.S.</ce:given-name>
                                 <ce:surname>Salvesen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.F.</ce:given-name>
                                 <ce:surname>Franke</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Stanbridge</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Frisch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.C.</ce:given-name>
                                 <ce:surname>Reed</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Regulation of cell death protease caspase-9 by phosphorylation</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>282</sb:volume-nr>
                              </sb:series>
                              <sb:date>1998</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1318</sb:first-page>
                              <sb:last-page>1321</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib15">
                     <ce:label>Cummins et al., 2004</ce:label>
                     <sb:reference id="sref15">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Cummins</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Kohli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Rago</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.W.</ce:given-name>
                                 <ce:surname>Kinzler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Vogelstein</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Bunz</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>64</sb:volume-nr>
                              </sb:series>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>3006</sb:first-page>
                              <sb:last-page>3008</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib16">
                     <ce:label>Dan et al., 2004</ce:label>
                     <sb:reference id="sref16">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.C.</ce:given-name>
                                 <ce:surname>Dan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Sun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Kaneko</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.I.</ce:given-name>
                                 <ce:surname>Feldman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.V.</ce:given-name>
                                 <ce:surname>Nicosia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.G.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.K.</ce:given-name>
                                 <ce:surname>Tsang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.Q.</ce:given-name>
                                 <ce:surname>Cheng</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP)</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>279</sb:volume-nr>
                              </sb:series>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>5405</sb:first-page>
                              <sb:last-page>5412</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib17">
                     <ce:label>Davoudi et al., 2014</ce:label>
                     <sb:reference id="sref17">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Davoudi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Akbarzadeh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Rahmatiyamchi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.A.</ce:given-name>
                                 <ce:surname>Movassaghpour</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Alipour</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Nejati-Koshki</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Sadeghi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Dariushnejad</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Zarghami</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Molecular target therapy of AKT and NF-kB signaling pathways and multidrug resistance by specific cell penetrating inhibitor peptides in HL-60 cells</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Asian Pac. J. Cancer Prev.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>15</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>4353</sb:first-page>
                              <sb:last-page>4358</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib18">
                     <ce:label>del Peso et al., 1997</ce:label>
                     <sb:reference id="sref18">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>del Peso</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>González-Garcıa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Page</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Herrera</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Nuñez</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Interleukin-3- induced phosphorylation of BAD through the protein kinase Akt</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>278</sb:volume-nr>
                              </sb:series>
                              <sb:date>1997</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>687</sb:first-page>
                              <sb:last-page>689</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib19">
                     <ce:label>Deveraux and Reed, 1999</ce:label>
                     <sb:reference id="sref19">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Q.L.</ce:given-name>
                                 <ce:surname>Deveraux</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.C.</ce:given-name>
                                 <ce:surname>Reed</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>IAP family proteins—suppressors of apoptosis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Genes Dev.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>13</sb:volume-nr>
                              </sb:series>
                              <sb:date>1999</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>239</sb:first-page>
                              <sb:last-page>252</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib20">
                     <ce:label>Dong et al., 2015</ce:label>
                     <sb:reference id="sref20">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Dong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Liang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Yuan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Gao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Tumor Biol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>36</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1477</sb:first-page>
                              <sb:last-page>1486</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib24">
                     <ce:label>Fulda and Debatin, 2006</ce:label>
                     <sb:reference id="sref24">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Fulda</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.M.</ce:given-name>
                                 <ce:surname>Debatin</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Oncogene</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>25</sb:volume-nr>
                              </sb:series>
                              <sb:date>2006</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>4798</sb:first-page>
                              <sb:last-page>4811</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib25">
                     <ce:label>Gillissen et al., 2013</ce:label>
                     <sb:reference id="sref25">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Gillissen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Richter</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Overkamp</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Essmann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.G.</ce:given-name>
                                 <ce:surname>Hemmati</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Preissner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Belka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.T.</ce:given-name>
                                 <ce:surname>Daniel</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent ‘type I’ mode</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cell Death Dis.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>4</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>e643</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib27">
                     <ce:label>Heras-Sandoval et al., 2014</ce:label>
                     <sb:reference id="sref27">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Heras-Sandoval</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.M.</ce:given-name>
                                 <ce:surname>Pérez-Rojas</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Hernández-Damián</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Pedraza-Chaverri</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cell. Signal.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>26</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2694</sb:first-page>
                              <sb:last-page>2701</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib30">
                     <ce:label>Huang et al., 2016</ce:label>
                     <sb:reference id="sref30">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Huang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.L.</ce:given-name>
                                 <ce:surname>O'Neill</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.B.</ce:given-name>
                                 <ce:surname>Gurumurthy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.M.</ce:given-name>
                                 <ce:surname>Quadros</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Tu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Luo</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Cleavage by caspase 8 and mitochondrial membrane association activate the BH3-only protein bid during TRAIL-induced apoptosis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>291</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>11843</sb:first-page>
                              <sb:last-page>11851</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib31">
                     <ce:label>Jeong et al., 2015</ce:label>
                     <sb:reference id="sref31">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.H.</ce:given-name>
                                 <ce:surname>Jeong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.S.</ce:given-name>
                                 <ce:surname>Chun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Kundu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Park</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Phosphorylation of Smac by Akt promotes the caspase-3 activation during etoposide-induced apoptosis in HeLa cells</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mol. Carcinog.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>54</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>83</sb:first-page>
                              <sb:last-page>92</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib33">
                     <ce:label>Kornfeld et al., 2013</ce:label>
                     <sb:reference id="sref33">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.W.</ce:given-name>
                                 <ce:surname>Kornfeld</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Baitzel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.C.</ce:given-name>
                                 <ce:surname>Könner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.T.</ce:given-name>
                                 <ce:surname>Nicholls</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.C.</ce:given-name>
                                 <ce:surname>Vogt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Herrmanns</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Scheja</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Haumaitre</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.M.</ce:given-name>
                                 <ce:surname>Wolf</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>U.</ce:given-name>
                                 <ce:surname>Knippschild</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Seibler</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nature</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>494</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>111</sb:first-page>
                              <sb:last-page>115</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib36">
                     <ce:label>Lee et al., 2004</ce:label>
                     <sb:reference id="sref36">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Waldman</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>PTEN gene targeting reveals a radiation-induced size checkpoint in human cancer cells</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>64</sb:volume-nr>
                              </sb:series>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>6906</sb:first-page>
                              <sb:last-page>6914</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib37">
                     <ce:label>Li et al., 1997</ce:label>
                     <sb:reference id="sref37">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Yen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Liaw</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Podsypanina</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Bose</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.I.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Puc</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Miliaresis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Rodgers</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.H.</ce:given-name>
                                 <ce:surname>Bigner</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>275</sb:volume-nr>
                              </sb:series>
                              <sb:date>1997</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1943</sb:first-page>
                              <sb:last-page>1947</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib38">
                     <ce:label>Liu et al., 2015</ce:label>
                     <sb:reference id="sref38">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Wei</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.Y.</ce:given-name>
                                 <ce:surname>Man</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Lu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.Q.</ce:given-name>
                                 <ce:surname>Zhu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.Z.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The MT2 receptor stimulates axonogenesis and enhances synaptic transmission by activating Akt signaling</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cell Death Differ.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>22</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>583</sb:first-page>
                              <sb:last-page>596</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib40">
                     <ce:label>Myers et al., 1997</ce:label>
                     <sb:reference id="sref40">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.P.</ce:given-name>
                                 <ce:surname>Myers</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.P.</ce:given-name>
                                 <ce:surname>Stolarov</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Eng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.I.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.H.</ce:given-name>
                                 <ce:surname>Wigler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Parsons</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.K.</ce:given-name>
                                 <ce:surname>Tonks</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Proc. Natl. Acad. Sci. U S A</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>94</sb:volume-nr>
                              </sb:series>
                              <sb:date>1997</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>9052</sb:first-page>
                              <sb:last-page>9057</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib41">
                     <ce:label>Nakatani et al., 2013</ce:label>
                     <sb:reference id="sref41">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Nakatani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Kleffmann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Linke</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.M.</ce:given-name>
                                 <ce:surname>Condon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.G.</ce:given-name>
                                 <ce:surname>Hinds</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.L.</ce:given-name>
                                 <ce:surname>Day</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Regulation of ubiquitin transfer by XIAP, a dimeric RING E3 ligase</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Biochem. J.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>450</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>629</sb:first-page>
                              <sb:last-page>638</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib42">
                     <ce:label>Özören and El-Deiry, 2002</ce:label>
                     <sb:reference id="sref42">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Özören</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.S.</ce:given-name>
                                 <ce:surname>El-Deiry</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Defining characteristics of Types I and II apoptotic cells in response to TRAIL</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Neoplasia</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>4</sb:volume-nr>
                              </sb:series>
                              <sb:date>2002</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>551</sb:first-page>
                              <sb:last-page>557</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib46">
                     <ce:label>Scaffidi et al., 1998</ce:label>
                     <sb:reference id="sref46">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Scaffidi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Fulda</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Srinivasan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Friesen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.J.</ce:given-name>
                                 <ce:surname>Tomaselli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.M.</ce:given-name>
                                 <ce:surname>Debatin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.H.</ce:given-name>
                                 <ce:surname>Krammer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.E.</ce:given-name>
                                 <ce:surname>Peter</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Two CD95 (APO-1/Fas) signaling pathways</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>EMBO J.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>17</sb:volume-nr>
                              </sb:series>
                              <sb:date>1998</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1675</sb:first-page>
                              <sb:last-page>1687</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib49">
                     <ce:label>Scott et al., 2005</ce:label>
                     <sb:reference id="sref49">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>F.L.</ce:given-name>
                                 <ce:surname>Scott</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.B.</ce:given-name>
                                 <ce:surname>Denault</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.J.</ce:given-name>
                                 <ce:surname>Riedl</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Shin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Renatus</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.S.</ce:given-name>
                                 <ce:surname>Salvesen</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>XIAP inhibits caspase-3 and-7 using two binding sites: evolutionarily conserved mechanism of IAPs</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>EMBO J.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>24</sb:volume-nr>
                              </sb:series>
                              <sb:date>2005</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>645</sb:first-page>
                              <sb:last-page>655</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib52">
                     <ce:label>Van Themsche et al., 2009</ce:label>
                     <sb:reference id="sref52">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Van Themsche</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Leblanc</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Parent</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Asselin</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>X-linked inhibitor of apoptosis protein (XIAP) regulates PTEN ubiquitination, content, and compartmentalization</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>284</sb:volume-nr>
                              </sb:series>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>20462</sb:first-page>
                              <sb:last-page>20466</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib53">
                     <ce:label>Wang and Youle, 2012</ce:label>
                     <sb:reference id="sref53">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.J.</ce:given-name>
                                 <ce:surname>Youle</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Predominant requirement of Bax for apoptosis in HCT116 cells is determined by Mcl-1's inhibitory effect on Bak</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Oncogene</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>31</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>3177</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib54">
                     <ce:label>Wang et al., 2010</ce:label>
                     <sb:reference id="sref54">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.Y.</ce:given-name>
                                 <ce:surname>Sun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Khuri</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.J.</ce:given-name>
                                 <ce:surname>Curran</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Deng</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Mono-or double-site phosphorylation distinctly regulates the proapoptotic function of Bax</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>PLoS One</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>5</sb:volume-nr>
                              </sb:series>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>e13393</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib55">
                     <ce:label>Wang et al., 2012</ce:label>
                     <sb:reference id="sref55">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.C.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Wei</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>An</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Zou</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Xiao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Bhagat</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>White</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Reichelt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Levine</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>338</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>956</sb:first-page>
                              <sb:last-page>959</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib57">
                     <ce:label>Wu, 2013</ce:label>
                     <sb:reference id="sref57">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Wu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Amino Acids: Biochemistry and Nutrition</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:book>
                              <sb:date>2013</sb:date>
                              <sb:publisher>
                                 <sb:name>CRC Press</sb:name>
                              </sb:publisher>
                           </sb:book>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib60">
                     <ce:label>Zhang et al., 2000</ce:label>
                     <sb:reference id="sref60">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.H.</ce:given-name>
                                 <ce:surname>Park</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.W.</ce:given-name>
                                 <ce:surname>Kinzler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Vogelstein</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Role of BAX in the apoptotic response to anticancer agents</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>290</sb:volume-nr>
                              </sb:series>
                              <sb:date>2000</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>989</sb:first-page>
                              <sb:last-page>992</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
               </ce:bibliography-sec>
            </ce:bibliography>
         </tail>
      </article>
   </xocs:serial-item>
</xocs:doc></originalText></full-text-retrieval-response>